Method for producing compound such as C-aryl alkoxy glycoside derivative

By contacting the compound (I) with the acid at a specific temperature and contacting it with the silane compound in the presence of Lewis acid, the problem of low yield in the manufacture of C-arylalkoxyglycoside derivatives was successfully solved, and the problem of low yield in the production of C-arylalkoxyglycoside derivatives was achieved Highly efficient compound production.

CN119019476APending Publication Date: 2024-11-26TOKUYAMA CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410622193.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-12-21
Filing Date
2024-05-20
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently manufacture C-arylalkoxyglycoside derivatives, and the yield is relatively low.

Method used

Compound (I) is contacted with an acid in a solvent containing an alcohol to produce compound (III), and then compound (III) is contacted with a silane compound in the presence of Lewis acid to produce compound (V). The method includes contacting the compound (I) with the acid at a temperature of -80°C or more than 40°C and contacting the compound (III) with the silane compound in the presence of Lewis acid to improve the reaction efficiency.

Benefits of technology

High yield manufacturing of C-arylalkoxyglycoside derivatives is achieved, and the reaction efficiency and purity of the product are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019476A_ABST
    Figure CN119019476A_ABST
Patent Text Reader

Abstract

The present invention relates to a method for producing a compound such as a C-arylalkoxyglucoside derivative. The purpose of the present invention is to provide a method with which it is possible to produce a compound such as a C-arylalkoxyglucoside derivative with high yield. The present invention provides a method for producing a compound (III) represented by formula (III), said method comprising a step for producing the compound (III) by bringing a compound (I) selected from the group consisting of compounds (Ia) represented by formula (Ia) and compounds (Ib) represented by formula (Ib) into contact with an acid in a solvent containing an alcohol (II) represented by formula (II). # imgabs0 # R100-OH (II), and a method for producing the same.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a method for producing compounds such as C-aryl alkoxy glycoside derivatives. Background Art

[0002] SGLT-2 inhibitors are useful as antidiabetic drugs. It should be noted that "SGLT-2" refers to sodium-glucose cotransporter-2. As SGLT-2 inhibitors, for example, canagliflozin (1-(β-D-pyranoglucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene), empagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol), empagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol), net ((1S)-1,5-anhydro-1-C-{3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl}-D-glucitol-(2S)-pyrrolidine-2-carboxylic acid), dapagliflozin ((2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethyloxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol), etc.

[0003] As a method for producing SGLT-2 inhibitors, a scheme has been proposed in which the protective group of a 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene precursor is deprotected to synthesize canagliflozin (see Patent Document 1). The 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene precursor is also called a C-arylhydroxyglycoside derivative and has attracted attention as an intermediate for producing SGLT-2 inhibitors (Patent Documents 1 to 2 and Non-Patent Documents 1 to 3).

[0004] Various methods for producing C-aryl hydroxyglycoside derivatives have been proposed, for example, the following methods are known: a method in which an aryl lithium is allowed to act on a D-gluconolactone derivative at an ultra-low temperature of -78°C to thereby perform an addition reaction of an aryl group (Non-Patent Documents 1 and 3); a method in which a turbo Grignard reagent such as ArMgBr·LiCl (Ar represents an aryl group) is allowed to act on a D-gluconolactone derivative at a low temperature of -20 to -10°C to thereby perform an addition reaction of an aryl group (Non-Patent Document 2); a method in which an aryl group is allowed to perform an addition reaction of an aryl group with a D-gluconolactone derivative using a magnesium ion complex obtained from tri-n-butyl magnesium lithium (nBu3MgLi) at a temperature environment of about -15°C (Patent Document 2); etc. In addition, it has been reported that a ketone derivative can be obtained by reacting an organic zinc reagent with a thioester derivative in the presence of a nickel catalyst to cause coupling (Non-Patent Documents 4 and 5).

[0005] In addition, Remdesivir represented by the following formula (X) is a compound that can be used as an antiviral drug. Remdesivir exhibits antiviral activity against single-stranded RNA viruses such as RS virus and coronavirus.

[0006] [Chemical formula 1]

[0007]

[0008] Patent document 3 discloses a method for producing remdesivir and its intermediates. Patent document 3 describes that by reacting a lactone represented by the following formula (XI) with a bromopyrazole represented by the following formula (Ar") at -78°C in the presence of chlorotrimethylsilane (TMSCl) and n-butyllithium, a hydroxy nucleoside represented by the following formula (XII) can be obtained. The hydroxy nucleoside can be used as an intermediate for the synthesis of remdesivir. It should be noted that "Bn" represents a benzyl group.

[0009] [Chemical formula 2]

[0010]

[0011] Prior art literature

[0012] Patent Literature

[0013] Patent Document 1: WO2010 / 043682

[0014] Patent Document 2: WO2015 / 012110

[0015] Patent Document 3: WO2012 / 012776

[0016] Non-patent literature

[0017] Non-patent document 1: J. Med. Chem. 2008, 51, 1145-1149

[0018] Non-patent document 2: Org. Lett. 2014, 16, 4090-4093

[0019] Non-patent document 3: J. Org. Chem. 1989, 54, 610-612

[0020] Non-patent document 4: Tetrahedron Letters 2002, 43, 1039-1042

[0021] Non-patent literature 5: Chem. Eur. J. 2018, 24, 8774-8778 Summary of the invention

[0022] Problems to be solved by the invention

[0023] C-aryl alkoxyglycoside derivatives can be obtained by a method comprising a step of obtaining a C-aryl hydroxyglycoside derivative from a gluconolactone derivative and a step of alkoxylating the C-aryl hydroxyglycoside derivative. However, it is difficult to produce C-aryl hydroxyglycoside derivatives in high yield by this method.

[0024] Therefore, there is a need for a method for producing compounds such as C-arylalkoxyglycoside derivatives in high yield.

[0025] An object of the present invention is to provide a method for producing compounds such as C-arylalkoxyglycoside derivatives in high yield.

[0026] Means for solving problems

[0027] The present invention includes the following inventions.

[0028] [1] A method for producing a compound (III) represented by the following formula (III), the method comprising the following steps:

[0029] Compound (III) is produced by contacting compound (I) selected from compound (Ia) represented by the following formula (Ia) and compound (Ib) represented by the following formula (Ib) with an acid in a solvent containing an alcohol (II) represented by the following formula (II).

[0030] [Chemical formula 3]

[0031]

[0032] [Wherein,

[0033] Ar represents an alkyl group which may have a substituent, an alkenyl group which may have a substituent, a cycloalkyl group which may have a substituent, a heterocycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heteroaryl group which may have a substituent, an arylalkyl group which may have a substituent, or an arylalkenyl group which may have a substituent,

[0034] R 100 represents an alkyl group which may have a substituent.]

[0035] [Chemical formula 4]

[0036]

[0037] [Wherein,

[0038] R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent, and Ar has the same meaning as above.]

[0039] [Chemical formula 5]

[0040]

[0041] [In the formula, R and Ar have the same meanings as above.]

[0042] [Chemical formula 6]

[0043] R 100 -OH (II)

[0044] [Where R 100 has the same meaning as above.]

[0045] [2] The method according to [1], wherein the compound (I) is contacted with the acid in the solvent at a temperature of -80°C to 40°C.

[0046] [3] The method according to [1] or [2], wherein the alcohol (II) is an alcohol having 1 to 5 carbon atoms.

[0047] [4] The method according to [3], wherein the alcohol (II) is methanol.

[0048] [5] The method according to any one of [1] to [4], wherein the acid is a compound (IV) represented by the following formula (IV).

[0049] [Chemical formula 7]

[0050]

[0051] [Where R 200 represents an alkyl group which may have a substituent or an aryl group which may have a substituent.]

[0052] [6] The method according to any one of [1] to [4], wherein the acid is sulfuric acid.

[0053] [7] A method for producing a compound (V) represented by the following formula (V), the method comprising the following steps:

[0054] After producing compound (III) by the method described in any one of [1] to [6], the produced compound (III) is brought into contact with a silane compound in the presence of a Lewis acid to produce the compound (V).

[0055] [Chemical formula 8]

[0056]

[0057] [In the formula, Ar has the same meaning as above.]

[0058] Effects of the Invention

[0059] According to the present invention, a method for producing compounds such as C-arylalkoxyglycoside derivatives in high yield can be provided. DETAILED DESCRIPTION

[0060] The present invention will be described below. When two or more embodiments described in this specification can be combined, the combination of the two or more embodiments is also included in the present invention.

[0061] 《Explanation of Terminology》

[0062] The following are terms used in this specification. Unless otherwise specified, the following description applies throughout this specification. It should be noted that, unless otherwise specified, the expression "value A to value B" means value A or more and value B or less.

[0063] Halogen Atom

[0064] The halogen atom is selected from a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.

[0065] alkyl

[0066] The number of carbon atoms in the alkyl group is, for example, 1 to 20, preferably 1 to 15, and more preferably 1 to 12 (e.g., 1 to 10, 1 to 8, 1 to 6, 1 to 5, 1 to 4, 1 to 3, or 1 to 2). The alkyl group may be linear or branched. The number of carbon atoms in a linear alkyl group is 1 or more, and the number of carbon atoms in a branched alkyl group is 3 or more.

[0067] Alkenyl

[0068] The number of carbon atoms of the alkenyl group is, for example, 2 to 20, preferably 2 to 15, and more preferably 2 to 12 (e.g., 2 to 10, 2 to 8, 2 to 6, 2 to 5, 2 to 4, or 2 to 3). The alkenyl group may be linear or branched. The number of carbon atoms of a linear alkenyl group is 2 or more, and the number of carbon atoms of a branched alkenyl group is 3 or more.

[0069] Cycloalkyl

[0070] The cycloalkyl group has, for example, 3 to 10 carbon atoms, preferably 3 to 8 carbon atoms, and more preferably 3 to 6 carbon atoms.

[0071] Heterocycloalkyl

[0072] Heterocycloalkyl is a monocyclic saturated aliphatic heterocyclic group, in which, as a ring-constituting atom, in addition to carbon atoms, one or more heteroatoms independently selected from the group consisting of oxygen atoms, sulfur atoms and nitrogen atoms are contained. Saturated aliphatic heterocyclic groups are aliphatic heterocyclic groups whose rings are composed only of saturated bonds. The number of heteroatoms is, for example, 1 to 4, preferably 1 to 3, and more preferably 1 or 2. The number of members of heterocycloalkyl is, for example, 3 to 8, preferably 4 to 7, more preferably 5 to 7, and further preferably 5 or 6. As heterocycloalkyl, for example, heterocycloalkyl containing 1 to 2 oxygen atoms, heterocycloalkyl containing 1 to 2 sulfur atoms, heterocycloalkyl containing 1 to 2 oxygen atoms and 1 to 2 sulfur atoms, heterocycloalkyl containing 1 to 4 nitrogen atoms, heterocycloalkyl containing 1 to 3 nitrogen atoms and 1 to 2 sulfur atoms and / or 1 to 2 oxygen atoms, etc. can be cited. Heterocycloalkyl preferably contains an oxygen atom as a heteroatom. Examples of the heterocycloalkyl group include aziridinyl, oxirane, thiirane, azetidinyl, oxetanyl, thietanyl, tetrahydrothiophenyl, tetrahydrofuranyl, pyrrolidinyl, imidazolidinyl, oxazolidinyl, pyrazolidinyl, thiazolidinyl, tetrahydroisothiazolyl, tetrahydrooxazolyl, tetrahydroisoxazolyl, piperidinyl, piperazinyl, tetrahydropyranyl, tetrahydrothiopyranyl, morpholinyl, thiomorpholinyl (the sulfur atom on the ring may be oxidized), azepanyl, diazepanyl, oxetanyl, azooctanyl, and diazaoctanyl.

[0073] In one embodiment, the heterocycloalkyl group is selected from tetrahydrofuranyl and tetrahydropyranyl. The heterocycloalkyl group is preferably tetrahydrofuranyl.

[0074] Aryl

[0075] The aryl group is, for example, a monocyclic or polycyclic (e.g., bicyclic or tricyclic) aromatic hydrocarbon ring group having 4 to 14 carbon atoms, preferably 6 to 14 carbon atoms, and more preferably 6 to 10 carbon atoms. The polycyclic group is preferably a condensed ring group. Examples of the aryl group include phenyl and naphthyl. The aryl group is preferably phenyl.

[0076] Heteroaryl

[0077] The heteroaryl group is a monocyclic or polycyclic (e.g., bicyclic or tricyclic) aromatic heterocyclic group, in which, as a ring-constituting atom, in addition to carbon atoms, one or more heteroatoms independently selected from the group consisting of oxygen atoms, sulfur atoms, and nitrogen atoms are contained. The polycyclic group is preferably a condensed ring. The number of heteroatoms is, for example, 1 to 4, preferably 1 to 3, and more preferably 1 or 2. The number of members of the heteroaryl group is preferably 4 to 14, and more preferably 5 to 10. As the heteroaryl group, for example, a heteroaryl group containing 1 to 2 oxygen atoms, a heteroaryl group containing 1 to 2 sulfur atoms, a heteroaryl group containing 1 to 2 oxygen atoms and 1 to 2 sulfur atoms, a heteroaryl group containing 1 to 4 nitrogen atoms, a heteroaryl group containing 1 to 3 nitrogen atoms and 1 to 2 sulfur atoms and / or 1 to 2 oxygen atoms, etc. can be cited. The heteroaryl group is preferably a monocyclic or bicyclic 4- to 10-membered (preferably 5- to 10-membered) aromatic heterocyclic group.

[0078] Examples of the monocyclic aromatic heterocyclic group include 5- to 7-membered monocyclic aromatic heterocyclic groups such as pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, thienyl, pyrrolyl, thiazolyl, isothiazolyl, pyrazolyl, imidazolyl, furyl, oxazolyl, isoxazolyl, oxadiazolyl (e.g., 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl), thiadiazolyl (e.g., 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl), triazolyl (e.g., 1,2,3-triazolyl, 1,2,4-triazolyl), tetrazolyl, and triazinyl.

[0079] Examples of the condensed polycyclic aromatic heterocyclic group include benzothiophenyl, benzofuranyl, benzimidazolyl, benzoxazolyl, benzisoxazolyl, benzothiazolyl, benzisothiazolyl, benzotriazolyl, imidazopyridyl, thienopyridyl, furopyridyl, pyrrolopyridyl, pyrazolopyridyl, oxazolopyridyl, thiazolopyridyl, imidazopyrazinyl, imidazopyrimidinyl, thienopyrimidinyl, furopyrimidinyl, pyrrolopyrimidinyl, pyrazolopyrimidinyl, 8-14 membered fused polycyclic (preferably bicyclic or tricyclic) aromatic heterocyclic groups such as pyrimidinyl, oxazolopyrimidinyl, thiazolopyrimidinyl, pyrazolotriazinyl, naphtho[2,3-b]thienyl, phenoxathiyl, indolyl, isoindolyl, 1H-indazolyl, purinyl, isoquinolyl, quinolyl, phthalazinyl, naphthyridinyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, α-carbolinyl, phenanthridinyl, acridinyl, phenazinyl, phenothiazinyl and phenoxazinyl.

[0080] In one embodiment, the heteroaryl group is selected from thienyl, benzothienyl, furanyl, pyrrolyl, imidazolyl and pyridinyl. The heteroaryl group is preferably selected from thienyl and benzothienyl.

[0081] Halogenated alkyl, halogenated aryl and halogenated heteroaryl

[0082] The halogenated alkyl group, halogenated aryl group and halogenated heteroaryl group are alkyl groups, aryl groups and heteroaryl groups having one or more halogen atoms, respectively, and the descriptions of the alkyl groups, aryl groups and heteroaryl groups are as described above. The number of halogen atoms possessed by the halogenated alkyl group, halogenated aryl group or halogenated heteroaryl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0083] Alkylene, arylene and heteroarylene

[0084] The alkylene group, arylene group and heteroarylene group are divalent functional groups generated by removing one hydrogen atom from an alkyl group, an aryl group and a heteroaryl group, respectively. The alkyl group, the aryl group and the heteroaryl group are as described above.

[0085] Halogenated alkylene, halogenated arylene and halogenated heteroarylene

[0086] The haloalkylene group, the haloarylene group and the haloheteroarylene group are divalent functional groups generated by removing one hydrogen atom from a haloalkyl group, a haloaryl group and a haloheteroaryl group, respectively. The haloalkyl group, the haloaryl group and the haloheteroaryl group are as described above.

[0087] Arylalkyl

[0088] The arylalkyl group is an alkyl group having one or more aryl groups, and the descriptions of the alkyl group and the aryl group are as described above. The number of aryl groups in the arylalkyl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0089] Arylene

[0090] The arylalkenyl group is an alkenyl group having one or more aryl groups, and the descriptions of the alkenyl group and the aryl group are as described above. The number of aryl groups possessed by the arylalkenyl group is, for example, 1 to 3, preferably 1 or 2, and more preferably 1.

[0091] Alkylcarbonyl and arylcarbonyl

[0092] The alkylcarbonyl group and the arylcarbonyl group are groups represented by the formula: -CO-alkyl and the formula: -CO-aryl, respectively, and the descriptions of the alkyl group and the aryl group are as described above.

[0093] Alkyloxy, haloalkyloxy, heterocycloalkyloxy and arylalkyloxy

[0094] The alkyloxy group, haloalkyloxy group, heterocycloalkyloxy group and arylalkyloxy group are groups represented by the formula: -O-alkyl group, the formula: -O-haloalkyl group, the formula: -O-heterocycloalkyl group and the formula: -O-arylalkyl group, respectively, and the descriptions of the alkyl group, the haloalkyl group, the heterocycloalkyl group and the arylalkyl group are as described above.

[0095] Alkylthio, haloalkylthio, heterocycloalkylthio and arylalkylthio

[0096] The alkylthio group, the haloalkylthio group, the heterocycloalkylthio group and the arylalkylthio group are groups represented by the formula: -S-alkyl, the formula: -S-haloalkyl, the formula: -S-heterocycloalkyl and the formula: -S-arylalkyl, respectively, and the descriptions of the alkyl group, the haloalkyl group, the heterocycloalkyl group and the arylalkyl group are as described above.

[0097] Alkyloxycarbonyl

[0098] The alkyloxycarbonyl group is a group represented by the formula: -CO-O-alkyl, and the description of the alkyl group is as described above. The number of carbon atoms in the alkyl group contained in the alkyloxycarbonyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2.

[0099] Amino

[0100] Amino group is of formula: -NH 2 Represents a group (primary amino group).

[0101] Monoalkylamino

[0102] A monoalkylamino group is of the formula: -NH(-Q 1 )[where Q 1 represents an alkyl group.] The group represented by [ is as described above for the alkyl group. 1 The number of carbon atoms in the alkyl group represented by is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2.

[0103] Dialkylamino

[0104] The dialkylamino group is of the formula: -N(-Q 2 )(-Q 3 )[where Q 2 and Q 3 Each independently represents an alkyl group. The group represented by ] has the same meaning as described above for the alkyl group. 2 or Q 3 The number of carbon atoms in the alkyl group represented by is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2.

[0105] Alicyclic amino

[0106] The alicyclic amino group is, for example, a 5- or 6-membered alicyclic amino group. As the 5- or 6-membered alicyclic amino group, for example, morpholino, thiomorpholino, pyrrolidin-1-yl, pyrazolidin-1-yl, imidazolidin-1-yl, piperidin-1-yl, etc. can be cited. The alicyclic amino group may include, in addition to the nitrogen atom having the connecting bond of the alicyclic amino group, a heteroatom (for example, 1 heteroatom) independently selected from the group consisting of an oxygen atom, a sulfur atom, and a nitrogen atom. The alicyclic amino group is preferably a morpholino group.

[0107] Aminocarbonyl, monoalkylaminocarbonyl, dialkylaminocarbonyl and alicyclic aminocarbonyl

[0108] The aminocarbonyl group, monoalkylaminocarbonyl group, dialkylaminocarbonyl group and alicyclic aminocarbonyl group are groups represented by the formula: -CO-amino group, the formula: -CO-monoalkylamino group, the formula: -CO-dialkylamino group and the formula: -CO-alicyclic amino group, respectively, and the monoalkylamino group, the dialkylamino group and the alicyclic amino group are as described above.

[0109] Substituents

[0110] The phrase "may have a substituent" means that the compound may have one or more substituents. The phrase "one or more substituents" means that the compound preferably has 1 to 3 substituents, and more preferably has one or two substituents.

[0111] Substituent group α

[0112] Substituent group α consists of the following substituents.

[0113] (α-1) Halogen atom

[0114] (α-2) Nitrile

[0115] (α-3) Nitro

[0116] (α-4)Amino

[0117] (α-5) alkyl

[0118] (α-6)Halogenated Alkyl

[0119] (α-7)monoalkylamino

[0120] (α-8)Dialkylamino

[0121] (α-9) alicyclic amino

[0122] (α-10)alkyloxycarbonyl

[0123] (α-11)aminocarbonyl

[0124] (α-12)Monoalkylaminocarbonyl

[0125] (α-13)Dialkylaminocarbonyl

[0126] (α-14)Alicyclic aminocarbonyl

[0127] (α-15) Hydroxyl group which may be protected by a protecting group

[0128] (α-16) Thiol group which may be protected by a protecting group

[0129] Substituent group β

[0130] Substituent group β consists of the following substituents.

[0131] (β-1) Substituent represented by formula (i)

[0132] (β-2) Substituent represented by formula (ii)

[0133] The substituent groups α and β are described below.

[0134] In (α-5), the number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2.

[0135] In (α-6), the number of carbon atoms in the haloalkyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2. The number of halogen atoms in the haloalkyl group is preferably 1 to 3, further preferably 1 or 2, further preferably 1.

[0136] (α-15) Hydroxyl group which may be protected by a protecting group

[0137] The hydroxy protecting group is preferably a group that can protect the hydroxyl group when the target reaction is carried out and can be separated from the hydroxyl group after the target reaction ends. As the hydroxy protecting group, for example, alkylcarbonyl type protecting group, arylcarbonyl type protecting group, arylalkyl type protecting group, alkyl type protecting group, arylalkyloxyalkyl type protecting group, alkyloxyalkyl type protecting group, silyl type protecting group, oxycarbonyl type protecting group, acetal type protecting group, aryl type protecting group etc. can be enumerated. These protecting groups can have more than one halogen atom.

[0138] Examples of the alkylcarbonyl type protecting group include alkylcarbonyl groups having 2 to 10 carbon atoms which may have one or more substituents. The substituent may be selected from, for example, a halogen atom, a nitro group, a cyano group, a phenyl group, an alkyl group having 1 to 10 carbon atoms (preferably 1 to 8 carbon atoms, more preferably 1 to 6 carbon atoms, and further preferably 1 to 4 carbon atoms), an alkyloxy group having 1 to 10 carbon atoms (preferably 1 to 8 carbon atoms, more preferably 1 to 6 carbon atoms, and further preferably 1 to 4 carbon atoms), and an alkyloxycarbonyl group having 2 to 11 carbon atoms (preferably 2 to 9 carbon atoms, more preferably 2 to 7 carbon atoms, and further preferably 2 to 5 carbon atoms). Examples of the alkylcarbonyl group having 2 to 10 carbon atoms which may have one or more substituents include acetyl, propionyl, butyryl, isopropionyl, and pivaloyl. The alkylcarbonyl-type protecting group is preferably an alkylcarbonyl group having 2 to 5 carbon atoms, more preferably an acetyl group or a pivaloyl group, and still more preferably an acetyl group.

[0139] As the arylcarbonyl type protecting group, for example, an arylcarbonyl group having 7 to 11 carbon atoms which may have one or more substituents can be mentioned. Specific examples of the substituent are the same as those of the alkylcarbonyl type protecting group. As the arylcarbonyl group having 7 to 11 carbon atoms which may have one or more substituents, for example, a benzoyl group, a 4-nitrobenzoyl group, a 4-methyloxybenzoyl group, a 4-methylbenzoyl group, a 4-tert-butylbenzoyl group, a 4-fluorobenzoyl group, a 4-chlorobenzoyl group, a 4-bromobenzoyl group, a 4-phenylbenzoyl group, a 4-methyloxycarbonylbenzoyl group, and the like can be mentioned.

[0140] As the arylalkyl type protecting group, for example, an arylalkyl group having 7 to 11 carbon atoms which may have one or more substituents can be mentioned. Specific examples of the substituent are the same as those of the alkylcarbonyl type protecting group. As the arylalkyl group having 7 to 11 carbon atoms which may have one or more substituents, for example, benzyl, 1-phenylethyl, diphenylmethyl, 1,1-diphenylethyl, naphthylmethyl, trityl, etc. can be mentioned. The arylalkyl type protecting group is preferably a benzyl group.

[0141] As the alkyl type protecting group, for example, an alkyl group having 1 to 10 carbon atoms which may have one or more substituents can be mentioned. Specific examples of the substituents are the same as those of the alkylcarbonyl type protecting group. The alkyl type protecting group is preferably an alkyl group having 1 to 5 carbon atoms which may have one or more substituents, more preferably a methyl group, an ethyl group, or a tert-butyl group, and even more preferably a methyl group.

[0142] As the arylalkyloxyalkyl type protecting group, for example, there can be mentioned arylalkyloxyalkyl groups such as arylalkyloxymethyl groups having 8 to 12 carbon atoms which may have one or more substituents, arylalkyloxyethyl groups having 9 to 13 carbon atoms which may have one or more substituents, and arylalkyloxypropyl groups having 10 to 14 carbon atoms which may have one or more substituents. Specific examples of the substituents are the same as those of the alkylcarbonyl type protecting group. The arylalkyloxyalkyl type protecting group is, for example, a benzyloxymethyl group which may have one or more substituents, preferably a benzyloxymethyl group which may be substituted with a halogen atom, a nitro group, a cyano group, a methyl group, or a methyloxy group, and more preferably a benzyloxymethyl group.

[0143] Examples of the alkyloxyalkyl type protecting group include alkyloxymethyl groups having 2 to 10 carbon atoms which may have one or more substituents, alkyloxyethyl groups having 3 to 10 carbon atoms which may have one or more substituents, and alkyloxypropyl groups having 4 to 10 carbon atoms which may have one or more substituents. Specific examples of the substituents are the same as those of the alkylcarbonyl type protecting group. The alkyloxyalkyl type protecting group is preferably an alkyloxymethyl group having 2 to 10 carbon atoms which may have one or more substituents, more preferably an alkyloxymethyl group having 2 to 6 carbon atoms which may have a halogen atom, a nitro group, a cyano group, a methyloxy group, or an ethyloxy group, and even more preferably a methyloxymethyl group.

[0144] As a silyl type protecting group, for example, there can be mentioned a silyl group having a functional group selected from an alkyl group having 1 to 10 carbon atoms which may have one or more substituents, an arylalkyl group having 7 to 11 carbon atoms which may have one or more substituents, and an aryl group having 6 to 10 carbon atoms which may have one or more substituents. Specific examples of the substituent are the same as those of the alkylcarbonyl type protecting group. The silyl type protecting group is preferably a silyl group having a functional group selected from an alkyl group having 1 to 10 carbon atoms and an aryl group having 6 to 10 carbon atoms, more preferably a silyl group having a functional group selected from an alkyl group having 1 to 5 carbon atoms and a phenyl group, and further preferably a trimethylsilyl group, a triethylsilyl group, a tert-butyldimethylsilyl group, or a tert-butyldiphenylsilyl group.

[0145] As the oxycarbonyl type protecting group, for example, an alkyloxycarbonyl group having 2 to 10 carbon atoms which may have one or more substituents, an alkenyloxycarbonyl group having 3 to 10 carbon atoms which may have one or more substituents, an arylalkyloxycarbonyl group having 8 to 12 carbon atoms which may have one or more substituents, etc. can be mentioned. Specific examples of the substituents are the same as those of the alkylcarbonyl type protecting group. The oxycarbonyl type protecting group is preferably an alkyloxycarbonyl group having 2 to 6 carbon atoms, an alkenyloxycarbonyl group having 3 to 6 carbon atoms, or a benzyloxycarbonyl group, and more preferably a methyloxymethyl group, an allyloxycarbonyl group, or a benzyloxycarbonyl group.

[0146] Examples of the acetal type protecting group include tetrahydrofuranyl and tetrahydropyranyl.

[0147] Examples of the aryl type protecting group include aryl groups such as phenyl.

[0148] The hydroxyl group protected by the protecting group is preferably a group represented by the formula: -OQ. Q represents an alkyl group, a halogenated alkyl group, an aryl group, a halogenated aryl group, a heterocycloalkyl group, an alkylcarbonyl group, an arylcarbonyl group or an arylalkyl group. The number of carbon atoms of the group represented by the formula: -OQ is preferably 1 to 10, more preferably 1 to 8. Q is preferably an alkyl group, a heterocycloalkyl group, an alkylcarbonyl group or an arylalkyl group, more preferably an ethyl group, a tetrahydrofuranyl group, an acetyl group or a benzyl group.

[0149] (α-16) Thiol group which may be protected by a protecting group

[0150] The thiol protecting group is preferably a group that can protect the thiol group when the target reaction is carried out and can be separated from the thiol group after the target reaction is completed. As the thiol protecting group, for example, an alkylcarbonyl type protecting group, an arylcarbonyl type protecting group, an arylalkyl type protecting group, an alkyl type protecting group, an arylalkyloxyalkyl type protecting group, an alkyloxyalkyl type protecting group, a silyl type protecting group, an oxycarbonyl type protecting group, an acetal type protecting group, an aryl type protecting group, etc. can be cited. These protecting groups can have more than one halogen atom. The description of these protecting groups is as described above.

[0151] The thiol group protected by a protecting group is preferably a group represented by the formula: -SQ. The description of Q is as described above.

[0152] (β-1) Substituent represented by formula (i)

[0153] [Chemical formula 9]

[0154]

[0155] In formula (i), R 11 , R 12 and R 13 Each independently represents an alkyl group, a halogenated alkyl group, an aryl group, a halogenated aryl group or a hydroxyl group which may be protected by a protecting group. The hydroxyl group which may be protected by a protecting group is preferably a group represented by the above formula: -OQ. a is 0 or more and 3 or less.

[0156] (β-2) Substituent represented by formula (ii)

[0157] [Chemical formula 10]

[0158] -(V 10 ) b -(W 10 ) c -(X 10 ) (ii)

[0159] In formula (ii), V 10 represents an alkylene group, a halogenated alkylene group, an arylene group, a halogenated arylene group, a heteroarylene group, a halogenated heteroarylene group, an ester bond, an ether bond or a carbonyl group. The number of carbon atoms of the alkylene group and the halogenated alkylene group is preferably 1 to 10, more preferably 1 to 8. The number of carbon atoms of the arylene group and the halogenated arylene group is preferably 4 to 14, more preferably 6 to 14. The number of carbon atoms of the heteroarylene group and the halogenated heteroarylene group is preferably 4 to 14. 10 It is preferably an alkylene group, and more preferably a methylene group or an ethylene group.

[0160] In formula (ii), b represents 0 or 1. b is preferably 1.

[0161] In formula (ii), W 10 W represents an alkylene group, a halogenated alkylene group, an arylene group, a halogenated arylene group, a heteroarylene group, a halogenated heteroarylene group, an ester bond, an ether bond or a carbonyl group. 10 It is preferably a heteroarylene group, more preferably a 5-membered heteroarylene group containing a sulfur atom as a hetero atom, and further preferably a thienylene group.

[0162] In formula (ii), c represents 0 or 1. Preferably, c is 1.

[0163] In formula (ii), X 10 represents a hydrogen atom, an alkyl group which may have a substituent, an aryl group which may have a substituent, or a heteroaryl group which may have a substituent. Each of the alkyl group, the aryl group, and the heteroaryl group may be unsubstituted or may have one or more substituents. One or more substituents may be independently selected from the substituent group α. The one or more substituents are preferably independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, a haloalkylthio group, a heterocycloalkyloxy group, and a heterocycloalkylthio group, more preferably selected from a halogen atom, an alkyloxy group having 1 to 3 carbon atoms, and a heterocycloalkyloxy group, and further preferably selected from a fluorine atom, an ethyloxy group, and a tetrahydrofuranyloxy group. The heterocycloalkyloxy group preferably contains an oxygen atom as a heteroatom. The number of substituents that each of the alkyl group, the aryl group, and the heteroaryl group may have is preferably 1 to 3, and more preferably 1 or 2.

[0164] X 10 It is preferably an aryl group which may have a substituent or a heteroaryl group which may have a substituent, more preferably an aryl group having a halogen atom, an alkyloxy group having 1 to 3 carbon atoms, or a heterocycloalkyloxy group, or an unsubstituted heteroaryl group, and further preferably a phenyl group having a fluorine atom, an ethyloxy group, or a tetrahydrofuranyloxy group, or an unsubstituted benzothienyl group. The heterocycloalkyloxy group preferably contains an oxygen atom as a heteroatom.

[0165] Compound (I)

[0166] The compound (I) is selected from a compound (Ia) represented by the following formula (Ia) and a compound (Ib) represented by the following formula (Ib).

[0167] [Chemical formula 11]

[0168]

[0169] [Chemical formula 12]

[0170]

[0171] In formula (Ia) and (Ib), R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The description of the alkyl group and the aryl group is as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3. The aryl group is preferably a phenyl group. The alkyl group and the aryl group may each be unsubstituted or may have one or more substituents. The number of substituents that the alkyl group and the aryl group may each have is preferably 1 to 3, more preferably 1 or 2. One or more substituents may each be independently selected from the substituent groups α and β. It is also possible to select one or more substituents from the substituent group α and one or more substituents from the substituent group β. The one or more substituents are preferably each independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and still more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0172] In formula (Ia) and (Ib), all R (4 R in formula (Ia), 5 R in formula (Ib)) may be different, but from the viewpoint of efficient introduction and removal of the hydroxyl protecting group represented by the formula: -CO-R, they are preferably the same. In one embodiment, all R are methyl. In another embodiment, all R are phenyl.

[0173] In formula (Ia) and (Ib), Ar represents:

[0174] (1) an alkyl group which may have a substituent,

[0175] (2) an alkenyl group which may have a substituent,

[0176] (3) a cycloalkyl group which may have a substituent,

[0177] (4) a heterocycloalkyl group which may have a substituent,

[0178] (5) an aryl group which may have a substituent,

[0179] (6) a heteroaryl group which may have a substituent,

[0180] (7) an arylalkyl group which may have a substituent, or

[0181] (8) An arylalkenyl group which may have a substituent.

[0182] The functional groups (1) to (8) are described below.

[0183] (1) Alkyl group which may have a substituent

[0184] The description of the alkyl group is as described above. The alkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0185] (2) Alkenyl group which may have a substituent

[0186] The description of the alkenyl group is as described above. The alkenyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0187] (3) Cycloalkyl group which may have a substituent

[0188] The description of the cycloalkyl group is as described above. The cycloalkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0189] (4) Heterocycloalkyl group which may have a substituent

[0190] The description of the heterocycloalkyl group is as described above. The heterocycloalkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0191] (5) Aryl group which may have a substituent

[0192] The description of the aryl group is as described above. The aryl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0193] (6) Heteroaryl group which may have a substituent

[0194] The description of the heteroaryl group is as described above. The heteroaryl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0195] (7) Arylalkyl group which may have a substituent

[0196] The description of the arylalkyl group is as described above. The arylalkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0197] (8) Arylene groups which may have a substituent

[0198] The description of the arylalkenyl group is as described above. The arylalkenyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β.

[0199] In the functional group (5) (i.e., the aryl group which may have a substituent), the carbon atoms located at the left and right ortho positions of the carbon atom having a bonding bond (i.e., the carbon atom bonded to -CO-) of the aryl group preferably have no substituent. The remaining carbon atoms may have a substituent.

[0200] In the functional group (6) (i.e., the heteroaryl group which may have a substituent), the carbon atoms or heteroatoms located at the left and right ortho positions of the carbon atom having a bonding bond (i.e., the carbon atom bonded to -CO-) of the heteroaryl group preferably have no substituent. The remaining carbon atoms or heteroatoms may have a substituent.

[0201] In one embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (1).

[0202] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (2).

[0203] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (3).

[0204] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (4).

[0205] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (5).

[0206] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (6).

[0207] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (7).

[0208] In another embodiment, all R are the same (eg, all R are methyl or phenyl), and Ar is functional group (8).

[0209] Ar is preferably a functional group represented by the following formula (iv). In one embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by the following formula (iv).

[0210] [Chemical formula 13]

[0211] -(Y 10 )-(V 10 ) b -(W 10 ) c -(X 10 ) (iv)

[0212] In formula (iv), Y 10represents an alkylene group which may have a substituent, an arylene group which may have a substituent, or a heteroarylene group which may have a substituent. The number of carbon atoms of the alkylene group is preferably 1 to 10, and more preferably 1 to 8. The number of carbon atoms of the arylene group is preferably 4 to 14, and more preferably 6 to 14. The number of carbon atoms of the heteroarylene group is preferably 4 to 14. Each of the alkylene group, the arylene group, and the heteroarylene group may be unsubstituted or may have one or more substituents. One or more substituents may be independently selected from the substituent group α. The one or more substituents are preferably independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, and more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms. The number of substituents that each of the alkylene group, the arylene group, and the heteroarylene group may have is preferably 1 to 3, and more preferably 1 or 2.

[0213] Y 10 An arylene group having a substituent is preferred, an arylene group having a halogen atom or an alkyl group having 1 to 3 carbon atoms is more preferred, and a phenylene group having a fluorine atom, a chlorine atom or a methyl group is further preferred.

[0214] Y 10 Preferably, it is an arylene group in which the carbon atoms located at the left and right ortho positions of the carbon atom bonded to -CO- have no substituent and the remaining carbon atoms may have a substituent, or a heteroarylene group in which the carbon atoms or hetero atoms located at the left and right ortho positions of the carbon atom bonded to -CO- have no substituent and the remaining carbon atoms or hetero atoms may have a substituent. 10 More preferably, it is a phenylene group which has no substituent at the ortho position and may have a substituent at the meta position and / or para position relative to the carbon atom bonded to -CO-.

[0215] In formula (iv), V 10 , W 10 , X 10 , b and c are each synonymous with those in formula (ii).

[0216] Alternatively, Ar is preferably a functional group represented by the following formula (vi): In one embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by the following formula (vi).

[0217] [Chemical formula 14]

[0218]

[0219] In formula (vi), R 41 and R 42Each independently represents a protecting group for a hydrogen atom or an amino group. As the protecting group for the amino group, any protecting group such as a carbamate group, an acyl group, an amide group, a sulfonamide group, a phthaloyl group, etc. can be used. As the protecting group for the carbamate group, for example, tert-butoxycarbonyl, benzyloxycarbonyl, 9-fluorenylmethyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, allyloxycarbonyl, etc. can be mentioned. As the protecting group for the acyl group, for example, acetyl, pivaloyl, benzoyl, etc. can be mentioned. As the protecting group for the amide group, for example, trifluoroacetyl, etc. can be mentioned. As the protecting group for the sulfonamide group, for example, p-toluenesulfonyl, 2-nitrobenzenesulfonyl, etc. can be mentioned. The protecting group for the amino group is preferably a protecting group for the acyl group or the amide group. The protecting group for the amino group is more preferably pivaloyl or trifluoroacetyl. R 41 and R 42 They may be bonded to each other to form a protecting group of an amino group such as a phthaloyl group. If Ar has the structure of formula (vi), compound (I) may be suitably used as an intermediate of remdesivir.

[0220] From the perspective of using compounds (Ia) and (Ib) as raw materials for producing SGLT-2 inhibitors or derivatives thereof, Ar in formulas (Ia) and (Ib) is preferably the same as the functional group possessed by the SGLT-2 inhibitor, or is a functional group obtained by derivatizing the functional group possessed by the SGLT-2 inhibitor.

[0221] Here, canagliflozin (1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene), empagliflozin ((1S)-1,5-anhydro-1-C-{4-chloro-3-[(4-{[(3S)-oxolan-3-yl]oxy}phenyl)methyl]phenyl}-D-glucitol), ipagliptin ((1S)-1,5-anhydro-1-C-{3 SGLT-2 inhibitors represented by succinimidyl-2-ol ((2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethyloxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol) have a functional group represented by the following formula (A).

[0222] Therefore, Ar in formula (Ia) and (Ib) is preferably a functional group represented by the following formula (A). In one embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by the following formula (A).

[0223] [Chemical formula 15]

[0224]

[0225] In formula (A), d represents an integer of 0 to 4. d is preferably 1 to 3, more preferably 1 or 2, and further preferably 1. When d is 2 or more, d R a It can be the same or different.

[0226] In formula (A), d Ra can be independently selected from the substituent group α. Preferably, d Ra are independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, and more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0227] In formula (A), Ar' is a functional group represented by the following formula (v).

[0228] [Chemical formula 16]

[0229] -(w 10 ) c -(X 10 ) (v)

[0230] In formula (v), W 10 , X 10 and c are each synonymous with formula (ii).

[0231] In formula (A), Ar' is preferably a functional group represented by the following formula (Ar'-1), (Ar'-2) or (Ar'-3).

[0232] [Chemical formula 17]

[0233]

[0234] In the formulae (Ar'-1), (Ar'-2) and (Ar'-3), p is an integer of 0 to 5. p is preferably an integer of 0 to 3, more preferably an integer of 0 to 2, and even more preferably 0 or 1.

[0235] In the formulas (Ar'-1), (Ar'-2) and (Ar'-3), p R b Each of the p R groups may be independently selected from Substituent Group α, an aryl group which may have one or more substituents selected from Substituent Group α, and a heteroaryl group which may have one or more substituents selected from Substituent Group α. bPreferably, each is independently selected from Substituent Group α and an aryl group which may have one or more substituents selected from Substituent Group α. Preferably, the one or more substituents selected from Substituent Group α are independently selected from halogen atoms, alkyl groups, haloalkyl groups, alkyloxy groups, haloalkyloxy groups, alkylthio groups, haloalkylthio groups, heterocycloalkyloxy groups and heterocycloalkylthio groups, more preferably from halogen atoms, alkyl groups having 1 to 3 carbon atoms, alkyloxy groups having 1 to 3 carbon atoms and heterocycloalkyloxy groups, and further preferably from fluorine atoms, ethyloxy groups and tetrahydrofuranyloxy groups. The number of substituents that each aryl group and heteroaryl group may have is preferably 1 to 3, more preferably 1 or 2.

[0236] When p is greater than 2, p R b It can be the same or different.

[0237] In the formula (Ar'-1), p is preferably 1, R b Preferably, the phenyl group may have a substituent, more preferably a phenyl group having a halogen atom, and still more preferably a phenyl group having a fluorine atom. The position to which the unsubstituted or substituted phenyl group is bonded is preferably the 2-position of the thiophene ring. In the phenyl group having a halogen atom, the position to which the halogen atom is bonded is preferably the 4-position of the benzene ring.

[0238] In the formula (Ar'-2), p is preferably 0.

[0239] In the formula (Ar'-3), p is preferably 1, R b An alkyloxy group which may have a substituent or a heterocycloalkyloxy group which may have a substituent is preferred. The alkyloxy group which may have a substituent is preferably an alkyloxy group having 1 to 3 carbon atoms, and more preferably a methoxy group or an ethoxy group. The heterocycloalkyloxy group which may have a substituent is preferably a tetrahydrofuranyloxy group. The position to which the alkyloxy group which may have a substituent or the heterocycloalkyloxy group which may have a substituent is bonded is preferably the 4-position of the benzene ring.

[0240] When d=1, the functional group represented by formula (A) is preferably a functional group represented by the following formula (B).

[0241] [Chemical formula 18]

[0242]

[0243] In formula (B), R a and Ar' have the same meanings as in formula (A).

[0244] The functional group represented by formula (A) or (B) is preferably a functional group represented by the following formula (Ar-1), (Ar-2), (Ar-3) or (Ar-4). In addition, "Et" represents an ethyl group.

[0245] [Chemical formula 19]

[0246]

[0247] In one embodiment, all R are the same (for example, all R are methyl groups or phenyl groups), and Ar is a functional group represented by formula (Ar-1).

[0248] In another embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by formula (Ar-2).

[0249] In another embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by formula (Ar-3).

[0250] In another embodiment, all R are the same (for example, all R are methyl or phenyl), and Ar is a functional group represented by formula (Ar-4).

[0251] Alcohol (II)

[0252] The alcohol (II) is represented by the following formula (II).

[0253] [Chemical formula 20]

[0254] R 100 -OH (II)

[0255] In formula (II), R 100 Represents an alkyl group which may have a substituent. The description of the alkyl group is as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 5, further preferably 1 to 4, further preferably 1 to 3. The alkyl group may be unsubstituted or may have one or more substituents. The number of substituents is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from substituent groups α and β. One or more substituents may be selected from substituent group α, and one or more substituents may be selected from substituent group β. The one or more substituents are preferably each independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and still more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0256] Examples of the alcohol (II) include methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, 2-methyl-2-propanol, 1-pentanol, 2-pentanol, 3-pentanol, 2-methyl-1-butanol, 2-methyl-2-butanol, 3-methyl-1-butanol, 3-methyl-2-butanol, neopentyl alcohol, n-hexanol, 2-hexanol, 3-hexanol, 2-methyl-1-pentanol, 3-methyl-1-pentanol, Alcohols having 1 to 10 carbon atoms such as 4-methyl-1-pentanol, 2-methyl-2-pentanol, 3-methyl-2-pentanol, 4-methyl-2-pentanol, 2-methyl-3-pentanol, 3-methyl-3-pentanol, 2,2-dimethyl-1-butanol, 2,3-dimethyl-1-butanol, 3,3-dimethyl-1-butanol, 2,3-dimethyl-2-butanol, 3,3-dimethyl-2-butanol and 2-ethyl-1-butanol.

[0257] 《Compound (III)》

[0258] The compound (III) is represented by the following formula (III): The compound (III) comprises a C-aryl alkoxy glycoside derivative.

[0259] [Chemical formula 21]

[0260]

[0261] In formula (III), Ar has the same meaning as in formulas (Ia) and (Ib).

[0262] In formula (III), R 100 has the same meaning as in formula (II).

[0263] 《Compound (IV)》

[0264] Compound (IV) is represented by the following formula (IV).

[0265] [Chemical formula 22]

[0266]

[0267] In formula (IV), R 200It represents an alkyl group which may have a substituent or an aryl group which may have a substituent. The description of the alkyl group and the aryl group is as described above. The alkyl group may be linear or branched. The number of carbon atoms in the alkyl group is preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3. The aryl group is preferably a phenyl group. The alkyl group and the aryl group may each be unsubstituted or may have one or more substituents. The number of substituents that the alkyl group and the aryl group may each have is preferably 1 to 3, more preferably 1 or 2. One or more substituents may be independently selected from the substituent groups α and β. It is also possible to select one or more substituents from the substituent group α and one or more substituents from the substituent group β. The one or more substituents are preferably each independently selected from a halogen atom, an alkyl group, a haloalkyl group, an alkyloxy group, a haloalkyloxy group, an alkylthio group, and a haloalkylthio group, more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, a haloalkyl group having 1 to 3 carbon atoms, an alkyloxy group having 1 to 3 carbon atoms, and a haloalkyloxy group having 1 to 3 carbon atoms, and still more preferably selected from a halogen atom, an alkyl group having 1 to 3 carbon atoms, and an alkyloxy group having 1 to 3 carbon atoms.

[0268] As R 200 Examples of the compound (IV) which is an alkyl group which may have a substituent include alkylsulfonic acids such as methanesulfonic acid.

[0269] As R 200 Examples of the compound (IV) which is an aryl group which may have a substituent include arylsulfonic acids such as p-toluenesulfonic acid and benzenesulfonic acid.

[0270] 《Compound (V)》

[0271] Compound (V) is represented by the following formula (V).

[0272] [Chemical formula 23]

[0273]

[0274] In formula (V), Ar has the same meaning as in formulas (Ia) and (Ib).

[0275] 《Method for producing compound (III)》

[0276] The method for producing compound (III) comprises the step of contacting compound (I) with an acid in a solvent containing alcohol (II) to produce compound (III).

[0277] As compound (I), one of compound (Ia) or (Ib) may be used, or both of compound (Ia) and (Ib) may be used. In addition, as compound (I), one compound selected from compound (Ia) and (Ib) may be used, or two or more compounds selected from compound (Ia) and (Ib) may be used.

[0278] When compound (I) is contacted with an acid in a solvent containing alcohol (II), the contact temperature is, for example, from -100°C to 50°C, preferably from -80°C to 40°C, more preferably from -75°C to 30°C, and the contact time is, for example, from 0.5 hours to 48 hours, preferably from 1 hour to 24 hours, more preferably from 1 hour to 17 hours. The contact of compound (I) with an acid in a solvent containing alcohol (II) can be carried out under an inert atmosphere (for example, an argon atmosphere or a nitrogen atmosphere).

[0279] When compound (Ia) is used as compound (I), if compound (Ia) is brought into contact with an acid in a solvent containing alcohol (II), compound (C) is generated by cyclization of compound (Ia), compound (D) is generated by the detachment of the hydroxyl protecting group R' from compound (C), and compound (III) is generated by alkoxylation of compound (D), thereby compound (III) can be obtained in high yield. The yield of compound (III) relative to compound (Ia) is, for example, 60% or more, preferably 70% or more, and more preferably 80% or more.

[0280] When compound (Ib) is used as compound (I), if compound (Ib) is contacted with an acid in a solvent containing alcohol (II), the generation of compound (F) by the detachment of the hydroxyl protecting group R' from compound (Ib), the generation of compound (D) by cyclization of compound (F), and the generation of compound (III) by alkoxylation of compound (D) are successively performed, thereby obtaining compound (III) in high yield. The yield of compound (III) relative to compound (Ib) is, for example, 60% or more, preferably 70% or more, and more preferably 80% or more.

[0281] The compound (C) produced by cyclization of the compound (Ia) is represented by the following formula (C): In the formula (C), R' represents a hydroxyl protecting group represented by the formula: -CO-R, and Ar and R have the same meanings as in the formula (Ia).

[0282] [Chemical formula 24]

[0283]

[0284] The compound (F) generated by the removal of the hydroxyl protective group R' from the compound (Ib) is represented by the following (F): In the formula (F), Ar has the same meaning as in the formula (Ib).

[0285] [Chemical formula 25]

[0286]

[0287] The compound (D) generated by the removal of the hydroxyl protecting group R' from the compound (C) or the cyclization of the compound (F) is represented by the following (D): In the formula (D), Ar has the same meaning as in the formulas (Ia) and (Ib).

[0288] [Chemical formula 26]

[0289]

[0290] The alkoxylation of compound (D) is carried out by continuously generating compound (E) by the removal of H2O from compound (D), and the formula: -OR 100 The addition of the group represented by to the compound (E) occurs, and the compound (III) is generated by alkoxylation of the compound (D). The acid participates in the detachment of H2O from the compound (D), and the alcohol (II) participates in the formula: -OR 100 Addition of a group represented by to compound (E).

[0291] The compound (E) generated by the elimination of H2O from the compound (D) is represented by the following formula (E). In the formula (E), Ar has the same meaning as in the formulas (Ia) and (Ib).

[0292] [Chemical formula 27]

[0293]

[0294] Compound (I) may be a commercially available product or may be produced according to a conventional method. Compound (I) may be produced according to a method for which the applicant of the present invention has applied for a patent (Japanese Patent Application No. 2023-214194).

[0295] The acid to be contacted with compound (I) can be selected from inorganic acids such as hydrochloric acid, sulfuric acid, phosphoric acid, etc.; organic acids such as acetic acid, propionic acid, pivalic acid, etc.; compound (IV), etc. One acid may be used alone, or two or more acids may be used in combination.

[0296] From the viewpoint of increasing the yield of compound (III), the acid to be contacted with compound (I) is preferably selected from inorganic acids and compound (IV). The inorganic acid is preferably sulfuric acid. Compound (IV) is preferably selected from methanesulfonic acid, p-toluenesulfonic acid and benzenesulfonic acid, and more preferably methanesulfonic acid.

[0297] In one embodiment, compound (Ia) is used as compound (I) and compound (IV) (preferably methanesulfonic acid) is used as the acid. In another embodiment, compound (Ib) is used as compound (I) and an inorganic acid (preferably sulfuric acid) is used as the acid.

[0298] Relative to 1 mol of compound (I), the amount of acid used is, for example, 0.05 mol or more and 20 mol or less, preferably 0.01 mol or more and 10 mol or less, and more preferably 0.05 mol or more and 5 mol or less. Regarding the amount of compound (I), when one compound is used as compound (I), it refers to the amount of the one compound, and when two or more compounds are used as compound (I), it refers to the total amount of the two or more compounds (the same below). Regarding the amount of acid used, when one acid is used, it refers to the amount of the one acid, and when two or more acids are used, it refers to the total amount of the two or more acids.

[0299] The contact of compound (I) with the acid is carried out in a solvent containing alcohol (II). Compound (I) and the acid may be contacted in a solvent containing alcohol (II) by mixing compound (I) and the acid in a solvent containing alcohol (II).

[0300] The solvent used for contacting the compound (I) with the acid may contain one type of alcohol (II) or two or more types of alcohol (II).

[0301] Alcohol (II) is a monovalent chain aliphatic alcohol. Alcohol (II) may be straight-chain or branched. The number of carbon atoms in alcohol (II) is, for example, 1 to 10. From the viewpoint of increasing the yield of compound (III), the number of carbon atoms in alcohol (II) is preferably 1 to 5, more preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2. That is, R 100 The number of carbon atoms in the alkyl group which may have a substituent is preferably 1 to 5, more preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2.

[0302] From the viewpoint of increasing the yield of compound (III), alcohol (II) is preferably selected from methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol and 2-methyl-2-propanol, and more preferably methanol.

[0303] The amount of alcohol (II) used is, for example, 1 mL to 30 mL, preferably 1 mL to 20 mL, and more preferably 1 mL to 10 mL, relative to 1 g of compound (I). The amount of alcohol (II) used refers to the amount of one alcohol when one alcohol (II) is used, and refers to the total amount of the two or more alcohols when two or more alcohols (II) are used.

[0304] The solvent used for contacting the compound (I) with the acid may contain one or more organic solvents other than the alcohol (II). Examples of the organic solvent other than alcohol (II) include polyols such as ethylene glycol, propylene glycol, and glycerol; polyol derivatives such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol dimethyl ether, and propylene glycol diethyl ether; ether solvents such as tetrahydrofuran (THF), 2-methyltetrahydrofuran, cyclopentyl methyl ether, dibutyl ether, 1,4-dioxane, tert-butyl methyl ether, diisopropyl ether, dimethoxyethane, and diethylene glycol dimethyl ether; ketone solvents such as acetone, methyl ethyl ketone, and diethyl ketone; ester solvents such as methyl acetate and ethyl acetate; halogenated hydrocarbon solvents such as dichloromethane (DCM), chloroform, carbon tetrachloride, 1,2-dichloroethane, and chlorobenzene; aromatic hydrocarbon solvents such as toluene and xylene; aliphatic hydrocarbon solvents such as hexane and heptane, and the like. The organic solvent can be selected from, for example, ethylene glycol, ethylene glycol monomethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, toluene, xylene, dichloromethane, chloroform, hexane, methyl acetate, and ethyl acetate. From the viewpoint of increasing the yield of compound (III), the organic solvent other than alcohol (II) is preferably tetrahydrofuran.

[0305] From the viewpoint of improving the yield of compound (III), the solvent used in the contact between compound (I) and the acid is preferably a mixed solvent of alcohol (II) and an ether solvent, more preferably a mixed solvent of methanol and tetrahydrofuran.

[0306] The amount of the solvent used in the contact between Compound (I) and the acid is, for example, 1 mL to 100 mL, preferably 2 mL to 50 mL, and more preferably 3 mL to 30 mL, based on 1 g of Compound (I).

[0307] Compound (III) can be separated from the reaction mixture by conventional methods. For example, after a step of contacting compound (I) with an acid in a solvent containing alcohol (II) to generate compound (III), compound (III) is extracted from the reaction mixture obtained by the step to obtain an extract (crude product) containing compound (III), and the obtained extract is purified to separate compound (III).

[0308] When compound (III) is extracted from the reaction mixture, an organic solvent is preferably used as the extraction solvent. One organic solvent may be used alone, or two or more organic solvents may be used in combination. The organic solvent used in the extraction of compound (III) from the reaction mixture is preferably different from the organic solvent used in the contact between compound (I) and the acid. The organic solvent used in the extraction of compound (III) from the reaction mixture is preferably ethyl acetate, methyl acetate, dichloromethane, chloroform, methyl tert-butyl ether, hexane, toluene, xylene, 1,4-dioxane, ether, dibutyl ether, cyclopentyl methyl ether or a mixed solvent thereof.

[0309] Compound (III) can be extracted from the reaction mixture by, for example, the following method.

[0310] First, a quenching solution (e.g., a saturated aqueous solution of sodium bicarbonate, etc.) and an organic solvent used as needed are added to the reaction mixture to quench the reaction. The reaction mixture to which the quenching solution and the organic solvent used as needed are added is stirred to separate it into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (A)".). After the organic layer (A) is taken out, an organic solvent can also be added to the aqueous layer to separate it into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (B)".), the organic layer (B) is taken out, and combined with the previously taken out organic layer (A) to obtain a total organic layer. Then, a residue containing compound (III) is obtained from the organic layer (A) or the total organic layer. For example, for the organic layer (A) or the total organic layer, after washing based on a washing solution (e.g., water, etc.), drying based on sodium sulfate, filtering, etc., as needed, it is concentrated under reduced pressure, thereby obtaining a residue containing compound (III). The residue containing compound (III) thus obtained is an example of an extract (crude product) containing compound (III).

[0311] Examples of purification treatments for the extract include silica gel column chromatography, recrystallization, and trituration.

[0312] Silica gel column chromatography can be performed according to a conventional method.

[0313] Recrystallization can be performed using two solvents. As the two solvents, mutually soluble (i.e. compatible) solvents are selected. Among the two solvents, one solvent is a solvent with a large solubility for compound (III) (hereinafter referred to as the "first solvent"), and the other solvent is a solvent with a small solubility for compound (III) (hereinafter referred to as the "second solvent").

[0314] Examples of the first solvent include methyl acetate, ethyl acetate, dichloromethane, chloroform, methyl tert-butyl ether, etc. The first solvent is preferably methyl tert-butyl ether.

[0315] Examples of the second solvent include heptane and hexane. The second solvent is preferably heptane or hexane.

[0316] Examples of the combination of the first solvent and the second solvent include ethyl acetate / hexane, ethyl acetate / heptane, methyl acetate / hexane, dichloromethane / hexane, chloroform / hexane, methyl tert-butyl ether / hexane, methyl tert-butyl ether / heptane, etc. Among them, methyl tert-butyl ether / hexane or methyl tert-butyl ether / heptane is preferred.

[0317] The recrystallization treatment of the extract can be performed by adding the first solvent to the extract, then adding the second solvent, stirring, and then standing, or by adding a mixture of the first solvent and the second solvent to the extract, stirring, and then standing. The volume ratio of the amount of the first solvent used to the amount of the second solvent used (the amount of the first solvent used / the amount of the second solvent used) is, for example, 1 / 1 to 1 / 10. The stirring time and the standing time can be adjusted appropriately.

[0318] The crystals of compound (III) produced by recrystallization can be separated by solid-liquid separation. Examples of solid-liquid separation methods include filtration and decantation. The separated crystals of C-arylhydroxyglycoside (II) can also be subjected to treatments such as washing and drying.

[0319] The grinding can be performed using a mixture of the first solvent and the second solvent. As a combination of the first solvent and the second solvent, for example, ethyl acetate / hexane, ethyl acetate / heptane, methyl acetate / hexane, dichloromethane / hexane, chloroform / hexane, methyl tert-butyl ether / hexane, methyl tert-butyl ether / heptane, etc. can be mentioned, among which methyl tert-butyl ether / hexane or methyl tert-butyl ether / heptane is preferred. The volume ratio of the first solvent to the second solvent in the mixture of the first solvent and the second solvent (volume of the first solvent / volume of the second solvent) is, for example, 1 / 1 to 1 / 10, preferably 1 / 1 to 1 / 5.

[0320] The structure of compound (III) can be confirmed by, for example, nuclear magnetic resonance (NMR) spectral analysis.

[0321] 《Method for producing compound (V)》

[0322] The method for producing compound (V) comprises the steps of producing compound (III) by the above method and then contacting the produced compound (III) with a silane compound in the presence of a Lewis acid to produce compound (V).

[0323] When compound (III) is brought into contact with a silane compound in the presence of a Lewis acid, the contact temperature is, for example, -80°C to 20°C, preferably -60°C to 10°C, more preferably -50°C to 0°C, and the contact time is, for example, 0.5 hour to 4 hours, preferably 0.5 hour to 3 hours, more preferably 0.5 hour to 2 hours. The contact of compound (III) with a silane compound in the presence of a Lewis acid can be carried out in an inert atmosphere (e.g., an argon atmosphere or a nitrogen atmosphere).

[0324] The silane compound acts as a reducing agent. Therefore, if compound (III) is brought into contact with the silane compound in the presence of a Lewis acid, the reduction reaction of compound (III) proceeds to generate compound (V). The yield of compound (V) relative to compound (III) is, for example, 60% or more, preferably 70% or more, and more preferably 80% or more.

[0325] Examples of the silane compound include triethylsilane, triisopropylsilane, phenylsilane, dimethylphenylsilane, tert-butyldimethylsilane, triisobutylsilane, trichlorosilane, trimethoxyhydrosilane, triethoxyhydrosilane, tetramethyldisiloxane, etc. One silane compound may be used alone, or two or more silane compounds may be used in combination.

[0326] From the viewpoint of improving the yield of compound (V), the silane compound is preferably selected from triethylsilane and triisopropylsilane, and triethylsilane is more preferred.

[0327] The amount of the silane compound used is, for example, 1 to 3 mol, preferably 1 to 2 mol, and more preferably 1 to 1.5 mol, relative to 1 mol of compound (III). The amount of the silane compound used refers to the amount of one silane compound when one silane compound is used, and refers to the total amount of the two or more silane compounds when two or more silane compounds are used.

[0328] The contact of the compound (III) with the silane compound is carried out in the presence of a Lewis acid.

[0329] Examples of the Lewis acid include BF3.Et2O (boron trifluoride ether complex), BF3.THF (boron trifluoride tetrahydrofuran), AlCl3, ZnCl2, FeCl3, titanium compounds, etc. One Lewis acid may be used alone, or two or more Lewis acids may be used in combination.

[0330] As titanium compounds, for example, compounds in which titanium is zero-valent, compounds in which titanium is two-valent, compounds in which titanium is three-valent, compounds in which titanium is four-valent, and the like are known, and any titanium compound may be used. As titanium compounds, there may be mentioned four-valent titanium salts or solvates thereof such as triisopropoxy titanium monochloride (IV), diisopropoxy titanium dichloride (IV), monoisopropoxy titanium trichloride (IV), titanium (IV) chloride, titanium (IV) bromide, titanium (IV) iodide, and titanium (IV) oxide; trivalent titanium salts or solvates thereof such as titanium (III) chloride and titanium (III) bromide; divalent titanium salts or solvates thereof such as titanium (II) chloride; and zero-valent titanium or solvates thereof such as metal Ti. As solvates, for example, there may be mentioned compounds coordinated with solvents such as water and tetrahydrofuran.

[0331] The titanium compound is preferably of the formula: TiR c r (OR d ) s [Where R c is a halogen atom, R d is a substituted or unsubstituted alkyl group, and r and s are integers of 0 to 4 satisfying r+s=3 or 4. ] is a trivalent or tetravalent titanium salt or a solvate thereof. c Preferably, it is a chlorine atom, a bromine atom or an iodine atom, and R d An alkyl group having 1 to 6 carbon atoms is preferred, and an alkyl group having 1 to 3 carbon atoms is more preferred.

[0332] The titanium compound is preferably triisopropoxy titanium (IV) chloride, diisopropoxy titanium (IV) dichloride, monoisopropoxy titanium (IV) trichloride, titanium (IV) chloride, titanium (III) chloride, etc., and more preferably titanium (IV) chloride. Titanium (IV) chloride has a low melting point and is liquid at room temperature, so it is preferred from the perspectives of easy handling and low cost.

[0333] From the viewpoint of increasing the yield of compound (V), the Lewis acid is preferably BF 3 ·Et 2 O.

[0334] The amount of the Lewis acid used is, for example, 0.1 mol to 5 mol, preferably 0.5 mol to 4 mol, and more preferably 1 mol to 3 mol, relative to 1 mol of compound (III). The amount of the Lewis acid used refers to the amount of the Lewis acid when one Lewis acid is used, and refers to the total amount of the two or more Lewis acids when two or more Lewis acids are used.

[0335] The contact of compound (III) with the silane compound in the presence of a Lewis acid is preferably carried out in a solvent. Compound (III), a silane compound and a Lewis acid can be mixed in a solvent, thereby contacting compound (III) with the silane compound in the presence of a Lewis acid. The solvent is preferably selected from organic solvents. One organic solvent can be used alone, or a mixed solvent of two or more organic solvents can be used. As the organic solvent, for example, monohydric alcohols such as methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, isobutanol, 2-methyl-2-propanol, etc.; polyhydric alcohols such as ethylene glycol, propylene glycol, glycerol, etc.; polyhydric alcohol derivatives such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol dimethyl ether, ethylene glycol diethyl ether, propylene glycol dimethyl ether, propylene glycol diethyl ether, etc.; tetrahydrofuran (THF), 2-methyltetra ... Ether solvents such as hydrofuran, cyclopentyl methyl ether, dibutyl ether, 1,4-dioxane, tert-butyl methyl ether, diisopropyl ether, dimethoxyethane, diglyme, etc.; ketone solvents such as acetone, methyl ethyl ketone, diethyl ketone, etc.; ester solvents such as methyl acetate, ethyl acetate, etc.; halogenated hydrocarbon solvents such as dichloromethane (DCM), chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, etc.; aromatic hydrocarbon solvents such as toluene and xylene; aliphatic hydrocarbon solvents such as hexane and heptane, etc. The organic solvent can be selected from ethylene glycol, ethylene glycol monomethyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, 1,4-dioxane, 1,2-dimethoxyethane, toluene, xylene, dichloromethane, chloroform, hexane, methyl acetate and ethyl acetate. From the viewpoint of improving the yield of compound (V), the organic solvent is preferably dichloromethane.

[0336] The amount of the solvent used in the contact between the compound (III) and the silane compound in the presence of the Lewis acid is, for example, 2 mL to 100 mL, preferably 3 mL to 50 mL, and more preferably 5 mL to 10 mL, based on 1 g of the compound (III).

[0337] Compound (V) can be separated from the reaction mixture by conventional methods. For example, after a step of contacting compound (III) with a silane compound in the presence of a Lewis acid to generate compound (V), compound (V) is extracted from the reaction mixture obtained by the step to obtain an extract (crude product) containing compound (V), and the obtained extract is purified to separate compound (V).

[0338] When compound (V) is extracted from the reaction mixture, an organic solvent is preferably used as an extraction solvent. One organic solvent may be used alone, or two or more organic solvents may be used in combination. The organic solvent used in the extraction of compound (V) from the reaction mixture is preferably different from the organic solvent used in the contact between compound (III) and the silane compound in the presence of a Lewis acid. The organic solvent used in the extraction of compound (V) from the reaction mixture is preferably ethyl acetate, methyl acetate, dichloromethane, chloroform, methyl tert-butyl ether, hexane, toluene, xylene, 1,4-dioxane, ether, dibutyl ether, cyclopentyl methyl ether or a mixed solvent thereof.

[0339] Compound (V) can be extracted from the reaction mixture by, for example, the following method.

[0340] First, a quenching solution (e.g., a saturated aqueous solution of sodium bicarbonate, etc.) and an organic solvent used as needed are added to the reaction mixture to quench the reaction. The reaction mixture to which the quenching solution and the organic solvent used as needed are added is stirred to separate it into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (C)".). After the organic layer (C) is taken out, an organic solvent can also be added to the aqueous layer to separate it into an aqueous layer and an organic layer (hereinafter referred to as "organic layer (D)".), the organic layer (D) is taken out, and combined with the previously taken out organic layer (C) to obtain a total organic layer. Then, a residue containing compound (V) is obtained from the organic layer (C) or the total organic layer. For example, for the organic layer (C) or the total organic layer, after washing based on a washing solution (e.g., water, etc.), drying based on sodium sulfate, filtering, etc., as needed, it is concentrated under reduced pressure, thereby obtaining a residue containing compound (V). The residue containing compound (V) thus obtained is an example of an extract (crude product) containing compound (V).

[0341] Examples of purification treatments for the extract include silica gel column chromatography, recrystallization, trituration, etc. The explanations of silica gel column chromatography, recrystallization, and trituration are the same as above.

[0342] Example

[0343] In the following Production Examples and Examples, "Ac" represents an acetyl group, "Et" represents an ethyl group, and "Me" represents a methyl group.

[0344] [Example 1]

[0345] Compound (2A) is prepared from compound (1A) according to the following reaction formula. Compound (1A) is (2R,3R,4S,5R)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-2-hydroxy-6-oxohexane-1,3,4,5-tetrayl tetraacetate, and compound (2A) is (3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, i.e., an intermediate of canagliflozin.

[0346] [Chemical formula 28]

[0347]

[0348] At -70°C, a solution of compound (1A) (500 mg, 0.79 mmol, 1 equivalent) in tetrahydrofuran (THF) (2.5 mL, 5 times the volume) was added with a solution of methanesulfonic acid (MSA) (382 mg, 3.98 mmol, 5 equivalents) in methanol (MeOH) (5 mL, 10 times the volume). The reaction mass was maintained at -70°C for 7 hours and then maintained at room temperature (RT) for 16 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and a saturated aqueous solution of sodium bicarbonate were added to the reaction mixture to quench the reaction. The organic layer was separated, washed with water (10 mL), dried with sodium sulfate, and filtered. The filtrate was vacuum-extracted and concentrated to obtain a crude compound. The crude compound was ground three times with hexane / methyl tert-butyl ether (MTBE) (1.1 mL in total, volume ratio 4 / 1) to purify the compound (2A) to obtain 358 mg (yield: 95% relative to compound (1A)) as a white solid. The obtained compound (2A) was used directly in the next step without additional purification.

[0349] The analysis results of the obtained compound (2A) are shown below.

[0350] FTIR(NaCl): 3393, 2926, 2855, 1554, 1508, 1436, 1232, 198, 1071, 1028, 832, 801, 757cm -1

[0351] 1H NMR (500MHz, DMSO-d6) δ (ppm): 7.57-7.52 (m, 2H), 7.39 (d, J=1.4Hz, 1H), 7.29 (dd, J=7.9, 1.7Hz, 1H), 7.24 (d, J=3. 6Hz, 1H), 7.17 (dd, J=9.9, 7.8Hz, 2H), 7.11 (d, J=8.0Hz, 1H), 6.73 (d, J=3.6Hz, 1H), 4.93 (d, J=5.5Hz, 1H), 4.67 (dd, J=24.4, 6.2Hz, 2H), 4.50 (dd, J=6.5, 5.5Hz, 1H), 4.12 (dt, J=45.4, 18.8Hz, 2H), 3.72 (ddd, J=11.5, 5.2, 1.7Hz, 1H) , 3.60-3.46(m, 2H), 3.41-3.33(m, 1H), 3.23-3.14(m, 1H), 2.92(s, 3H), 2.90-2.83(m, 1H), 2.22(s, 3H), 1.20(s, 1H)

[0352] 13 C{ 1 H}NMR (126MHz, DMSO-d6, 30℃) δ (ppm): 161.57 (d, 1 J C-F =244.4Hz), 144.03(d, 5 J C-F =1.4Hz), 140.38, 137.45, 137.15, 135.36, 130.75(d, 4 J C-F =3.3Hz), 129.63, 128.99, 127.14(d, 3 J C-F =8.2Hz), 126.42, 126.29, 123.61, 116.11(d, 2 J C-F =22.68Hz), 101.08, 77.25, 74.55, 74.05, 70.40, 61.13, 48.42, 33.87, 18.94

[0353] 19 F NMR (471MHz, DMSO-d6, 30℃) δ (ppm): 114.98

[0354] HRMS: [M+Na] + C 25 H 27 FNaO6S calculated value: 497.1410, measured value: 497.1405

[0355] [Example 2]

[0356] Compound (3A) is prepared from compound (2A) according to the following reaction formula. Compound (3A) is (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., canagliflozin.

[0357] [Chemical formula 29]

[0358]

[0359] Triethylsilane (TES) (165.4 mg, 1.422 mmol, 2.25 equiv) was slowly added to a dichloromethane (DCM) solution (3 mL, 10-fold volume) of compound (2A) (300 mg, 0.632 mmol, 1.0 equiv) at -45°C, and then 48% boron trifluoride etherate (BF3·Et2O) (374 mg, 1.264 mmol, 2.0 equiv) was slowly added at -45°C over 30 minutes. The resulting mixture was stirred at -45°C for 2 hours and then maintained at 0°C for 1 hour. The completion of the reaction was confirmed by TLC. A saturated aqueous solution of sodium bicarbonate (5 mL) was added to the reaction mixture to adjust the pH to 7-8, thereby quenching the reaction. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The filtrate was concentrated by vacuum suction at 40-50°C to obtain a crude residue. The crude residue was purified by silica gel column chromatography (methanol / dichloromethane = 0.2 / 9.8 to 0.5 / 9.5) to obtain 227 mg (yield relative to compound (2A): 81%) of compound (3A) as a white solid.

[0360] The analysis results of the obtained compound (3A) are shown below.

[0361] Melting point (Mp): 114-118°C

[0362] FTIR(NaCl): 3377, 2924, 1509, 1231, 1095, 955, 896, 832cm -1

[0363] 1H NMR (500MHz, DMSO-d6) δ (ppm): 7.64-7.56 (m, 2H), 7.27 (d, J=3.6Hz, 1H), 7.24-7.17 (m, 3H), 7. 16-7.09 (m, 2H), 6.80 (d, J=3.6Hz, 1H), 4.96 (d, J=5.0Hz, 2H), 4.76 (d, J=5.8Hz, 1H), 4.47 (t, J= 5.8Hz, 1H), 4.12 (q, J=15.9Hz, 2H), 3.97 (d, J=9.4Hz, 1H), 3.70 (ddd, J=11.7, 5.4, 1.8Hz, 1H), 3 .45 (dd, J=11.9, 5.9Hz, 1H), 3.30-3.20 (m, 2H), 3.17 (ddd, J=14.5, 6.1, 3.0Hz, 2H), 2.26 (s, 3H)

[0364] 13 C{ 1 H}NMR (126MHz, DMSO-d6, 30℃) δ (ppm): 161.91 (d, 1 J C-F =244.4Hz), 144.17(d, 5 J C-F =1.3Hz), 140.76, 138.76, 137.93, 135.51, 131.05(d, 4 J C-F =3.4Hz), 130.21, 129.60, 127.49(d, 3 J C-F =8.2Hz), 126.92, 126.80, 123.93, 116.44(d, 2 J C-F =21.42Hz), 81.86, 81.74, 79.01, 75.22, 70.94, 61.95, 33.98, 19.36

[0365] 19 F NMR (471MHz, DMSO-d6, 30℃) δ (ppm): 114.97

[0366] HRMS: [M+Na] + C 24 H 25 NaFO5S calculated value: 467.1304, measured value: 467.1299

[0367] [Example 3]

[0368] Compound (2B) is prepared from compound (1B) according to the following reaction formula: Compound (2B) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, which is an intermediate of dapagliflozin.

[0369] [Chemical formula 30]

[0370]

[0371] At -78°C, a solution of compound (1B) (300 mg, 0.5068 mmol, 1 eq) in tetrahydrofuran (THF) (1.5 mL) was added dropwise with a solution of methanesulfonic acid (MSA) (95 mg, 2.5338 mmol, 5 eq) in methanol (MeOH) (3 mL), stirred at -78°C for 2 hours, slowly allowed to reach room temperature (RT), and stirred at room temperature for 12 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and aqueous sodium bicarbonate solution (10 mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, and filtered. The filtrate was vacuum-pumped and concentrated to obtain a light yellow solid. The obtained solid was dissolved in methyl tert-butyl ether (MTBE) (2 mL), and n-pentane (5 mL) was added to recrystallize. The obtained white solid was separated by filtration and dried to obtain 212 mg (yield relative to compound (1B): quantitative yield) of compound (2B) as a white solid. The obtained compound (2B) was used in the next step without additional purification.

[0372] The analysis results of the obtained compound (2B) are shown below.

[0373] 1 H NMR (500MHz, DMSO-d6) δ (ppm): 7.33 (s, 1H), 7.23 (dd, J=14.2, 7.4Hz, 2H), 7.01 ( d, J=8.4Hz, 2H), 6.73 (d, J=8.4Hz, 2H), 4.89 (d, J=87.6Hz, 2H), 4.01-3.94 (m, 2H) , 3.91 (dd, J=13.9, 6.8Hz, 3H), 3.82 (d, J=13.5Hz, 3H), 3.56 (s, 1H), 3.50 (d, J=9 .5Hz, 1H), 3.17 (t, J=8.5Hz, 1H), 2.92 (s, 1H), 2.88 (s, 3H), 1.33 (t, J=6.9Hz, 3H)

[0374] 13C NMR (126MHz, DMSO-d6, 30℃) δ (ppm): 157.40, 138.70, 136.61, 134.48, 131.42, 130.06, 129.73, 1 29.35, 126.73, 114.47, 101.05, 74.80, 72.52, 70.10, 63.45, 62.06, 49.30, 38.56, 27.07, 14.94

[0375] [Example 4]

[0376] Compound (3B) is produced from compound (2B) according to the following reaction formula. Compound (3B) is dapagliflozin.

[0377] [Chemical formula 31]

[0378]

[0379] Under an argon atmosphere, triethylsilane (TES) (96 μL, 0.4566 mmol, 2 equiv) was added dropwise to a dichloromethane (DCM) solution (1 mL) of compound (2B) (100 mg, 0.2283 mmol, 1 equiv) at -40°C, and then boron trifluoride ether complex (BF3·Et2O) (95 mg, 0.4566 mmol, 2 equiv) was added dropwise at -40°C, and stirred at -40°C for 1 hour. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and aqueous sodium carbonate solution (10 mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, and filtered. The filtrate was vacuum-pumped and concentrated to obtain a light yellow solid. The obtained solid was dissolved in methyl tert-butyl ether (MT BE) (1 mL), and n-pentane (3 mL) was added to recrystallize. The obtained white solid was separated by filtration and dried to obtain 86 mg (yield relative to compound (2B): 93%) of compound (3B) as a white solid.

[0380] The analysis results of the obtained compound (3B) are shown below.

[0381] 1H NMR (500MHz, DMSO-d6) δ (ppm): 7.33 (d, J=8.2Hz, 1H), 7.29 (d, J=1.9Hz, 1H), 7. 19 (dd, J=8.2, 1.9Hz, 1H), 7.05 (t, J=5.8Hz, 2H), 6.79 (d, J=8.6Hz, 2H), 4.94 (t , J=4.8Hz, 1H), 4.81 (t, J=6.0Hz, 1H), 4.43 (t, J=5.8Hz, 1H), 3.96-3.88 (m, 5H) , 3.69-3.61(m, 1H), 3.43-3.36(m, 1H), 3.24-3.02(m, 3H), 1.26(t, J=7.0Hz, 3H)

[0382] <Production Example 1>

[0383] According to the following reaction formula, compound (5) is prepared from compound (4), and compound (1B') is prepared from compound (5). Compound (4) is (2R,3S,4R,5R)-2,3,4,5,6-pentaacetoxyhexanoic acid, compound (5) is (2R,3R,4S,5R)-6-chloro-6-oxohexane-1,2,3,4,5-pentaacetate, and compound (1B') is (2R,3R,4S,5R)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-oxohexane-1,2,3,4,5-pentaacetate.

[0384] [Chemical formula 32]

[0385]

[0386] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv) in dichloromethane (DCM) was added N,N-dimethylformamide (DMF) (exactly 2-3 drops, about 0.05 equiv), and then oxalyl chloride (COCl) 2 (156 mg, 1.231 mmol, 2.0 equiv) was added at 0°C. The reaction mixture was stirred at room temperature for 2 hours under an argon atmosphere. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum suction for 2 hours to obtain compound (5). The obtained compound (5) was used directly in the subsequent operation.

[0387] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, exactly 1-2 drops) was added to a mixture containing flaked magnesium (30 mg, 1.231 mmol, 2.0 equivalents) and tetrahydrofuran (THF) (3 mL, 10 volumes) under an argon atmosphere. Then, 4-bromo-1-chloro-2-(4-ethoxybenzyl)benzene (200 mg, 0.615 mmol, 1.0 equivalents) was added under an argon atmosphere. Then, the reaction mixture was refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL×2). Thus, a Grignard reagent was prepared.

[0388] In another oven-dried Schlenk tube, a THF solution (2 mL×1) of compound (5) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. Then, the Grignard reagent prepared above was added dropwise to the reaction mixture at -15°C over 30 minutes, and stirred at -15°C for 1 hour. The reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a celite pad, and the filter bed was washed with ethyl acetate (10 mL×2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum suction to obtain a crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane=1 / 9 to 4 / 6) to obtain 300 mg (yield 77%) of compound (1B') as an off-white fluffy solid.

[0389] The analysis results of the obtained compound (1B') are shown below.

[0390] 1H NMR (500MHz, CDCl3, 25°C): δ7.74 (d, J=2.1Hz, 1H), 7.70 (dd, J=8.3, 2.2Hz, 1H), 7.47 (d, J=8.3Hz, 1H), 7 .12-7.07 (m, 2H), 6.84-6.80 (m, 2H), 6.00 (d, J=5.1Hz, 1H), 5.67 (dd, J=5.0, 4.3Hz, 1H), 5.44 (dd, J=7.0 , 4.3Hz, 1H), 5.09 (ddd, J=7.0, 5.8, 2.9Hz, 1H), 4.29 (dd, J=12.5, 2.9Hz, 1H), 44.08 (dd, J=12.1, 5.9Hz , 3H), 4.00 (q, J=7.0Hz, 2H), 2.10 (s, 3H), 2.05 (s, 3H), 2.04 (s, 3H), 2.04 (s, 3H), 1.93 (s, 3H), 1.39 (t, J 7.0Hz, 3H).

[0391] 13 C NMR (126MHz, CDCl3, 25℃): δ192.35, 170.65, 169.81, 169.64, 169.63, 169.44, 157.63, 140.14, 133.50, 130.93, 130.41, 130 .06, 129.87, 127.42, 114.60, 72.32, 69.27, 68.64, 68.50, 63.38, 61.71, 38.30, 20.73, 20.66, 20.49, 20.35, 20.28, 14.83.

[0392] [Example 5]

[0393] Compound (2B) is prepared from compound (1B') according to the following reaction formula. Compound (2B) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, which is an intermediate of dapagliflozin.

[0394] [Chemical formula 33]

[0395]

[0396] At -15°C, a solution of compound (1B') (100 mg, 0.157 mmol) in tetrahydrofuran (THF) (1 mL) was added dropwise with a methanol (MeOH) solution (2 mL) of sulfuric acid (H2SO4) (67 μL, 1.259 mmol), stirred at -15°C for 2 hours, then slowly allowed to reach room temperature (RT), and stirred at room temperature for 12 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and a saturated aqueous solution of sodium bicarbonate (10 mL) were added to the reaction mixture to quench the reaction. The organic layer was separated, dried over sodium sulfate, vacuum-sucked, and concentrated to obtain a crude product in the form of a sticky off-white solid. The obtained crude product was purified by column chromatography (methanol / chloroform = 0.5 / 9.5) to obtain 38 mg (yield 56%) of compound (2B) in the form of an off-white amorphous solid.

[0397] The analysis results of the obtained compound (2B) are shown below.

[0398] 1 H NMR (500MHz, CDCl3, 25°C): δ7.35 (s, 1H), 7.23 (s, 2H), 7.01 (d, J=8.7Hz, 2H), 6.72 (d , J=8.7Hz, 2H), 5.35 (s, 1H), 5.20 (s, 1H), 4.25 (d, J=7.3Hz, 1H), 4.00-3.92 (m, 2H), 3.93-3.87 (m, 2H), 3.80 (dt, J=24.6, 10.0Hz, 3H), 3.56 (t, J=9.4Hz, 1H), 3.47 (d, J= 9.8Hz, 1H), 3.31 (s, 1H), 3.18 (t, J=8.1Hz, 2H), 2.85 (s, 3H), 1.32 (t, J=7.0Hz, 3H).

[0399] <Production Example 2>

[0400] According to the following reaction formula, compound (4) is used to produce compound (5), and compound (1C') is used to produce compound (1C'). Compound (1C') is (2R,3R,4S,5R)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-oxohexane-1,2,3,4,5-pentayl pentaacetate.

[0401] [Chemical formula 34]

[0402]

[0403] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv) in dichloromethane (DCM) was added N,N-dimethylformamide (DMF) (exactly 2-3 drops, about 0.05 equiv), and then oxalyl chloride (COCl) 2 (156 mg, 1.231 mmol, 2.0 equiv) was added at 0°C. The reaction mixture was stirred at room temperature for 2 hours under an argon atmosphere. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum suction for 2 hours to obtain compound (5). The obtained compound (5) was used directly in the subsequent operation.

[0404] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, exactly 1-2 drops) was added to a mixture containing flaked magnesium (30 mg, 1.231 mmol, 2.0 equiv) and THF (3 mL, 10 volumes) under an argon atmosphere. Then, 2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene (197 mg, 0.615 mmol, 1.0 equiv) was added under an argon atmosphere. Then, the reaction mixture was refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL×2). Thus, a Grignard reagent was prepared.

[0405] In another oven-dried Schlenk tube, a THF solution (2 mL×1) of compound (5) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. The Grignard reagent prepared above was added dropwise to the obtained reaction mixture at -15°C over 30 minutes, and the mixture was stirred at -15°C for 2 hours. The reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a celite pad, and the filter bed was washed with ethyl acetate (10 mL×2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum suction to obtain a crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane=1 / 9 to 4 / 6) to obtain 256 mg (yield: 66%) of compound (1C') as an off-white fluffy solid.

[0406] The analysis results of the obtained compound (1C') are shown below.

[0407] 1H NMR (500MHz, CDCl3, 25°C): δ7.95 (dd, J=7.1, 2.3Hz, 1H), 7.86 (ddd, J=8.5, 4.9, 2.3Hz, 1H), 7.75-7.72 (m, 1H), 7 .66 (dd, J=7.3, 0.8Hz, 1H), 7.32-7.28 (m, 1H), 7.28-7.24 (m, 1H), 7.17 (t, J=8.9Hz, 1H), 7.04 (s, 1H), 6.05 (d, J= 5.1Hz, 1H), 5.72-5.66 (m, 1H), 5.45 (dd, J=6.8, 4.5Hz, 1H), 5.11-5.04 (m, 1H), 4.30 (dd, J=19.8, 9.3Hz, 2H), 4. 26-4.23 (m, 1H), 4.00 (dd, J=12.5, 5.9Hz, 1H), 2.09 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 2.02 (s, 3H), 1.93 (s, 3H).

[0408] 13 C NMR (126MHz, CDCl3, 25℃): δ191.74, 170.80, 169.92, 169.79, 169.74, 169.54, 1 65.23, 163.19, 142.36, 140.01, 139.80, 132.10, 132.06, 131.49, 129.79, 129. 71, 127.83, 127.70, 124.38, 124.03, 123.22, 122.39, 122.21, 116.43, 116.24, 72.44, 69.49, 68.82, 68.65, 61.77, 29.82, 20.80, 20.75, 20.56, 20.42, 20.36.

[0409] [Example 6]

[0410] Compound (2C) is prepared from compound (1C') according to the following reaction formula. Compound (2C) is (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, an intermediate of empagliflozin.

[0411] [Chemical formula 35]

[0412]

[0413] At -15°C, a solution of compound (1C') (150 mg, 0.237 mmol) in tetrahydrofuran (THF) (1 mL) was added dropwise with a methanol (MeOH) solution (1.5 mL) of methanesulfonic acid (MSA) (107 μL, 1.664 mmol), and then slowly allowed to reach room temperature, and stirred at room temperature for 12 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and aqueous sodium bicarbonate solution (5 mL) were added to the reaction mixture to quench the reaction. Next, the organic layer was separated, dried over sodium sulfate, and concentrated by vacuum suction to obtain a crude compound. The crude compound obtained was purified by silica gel column chromatography (methanol / chloroform = 0.5 / 9.5 to 1 / 9) to obtain 67 mg (yield 65%) of compound (2C) in the form of an off-white solid.

[0414] The analysis results of the obtained compound (2C) are shown below.

[0415] 1 H NMR (500MHz, CDCl3, 25°C): δ7.60 (d, J=8.0Hz, 1H), 7.53 (d, J=7.9Hz, 1H), 7.44 (d , J=7.2Hz, 1H), 7.33-7.30 (m, 1H), 7.21-7.16 (m, 1H), 7.16-7.10 (m, 1H), 6.94-6 .88(m,2H),5.33(s,1H),5.17(s,1H),4.23-4.04(m,3H),3.92-3.70(m,3H),3.6 0 (t, J=8.9Hz, 1H), 3.47 (d, J=9.6Hz, 1H), 3.34 (s, 1H), 3.19 (s, 1H), 2.84 (s, 3H).

[0416] 13 C NMR (126MHz, CDCl3, 25℃): δ159.87, 143.64, 140.03, 140.02, 140.01, 140.00, 139.64, 139.62, 139.60, 134.06, 134.03, 126.23, 126.10, 124.27 ,123.81,123.08,122.15,121.71,121.68,101.08,77.34,77.08,76.89 ,74.77,74.75,72.65,70.07,61.90,61.88,61.87,61.86,49.20,30.32.

[0417] [Example 7]

[0418] Compound (3C) is prepared from compound (2C) according to the following reaction formula. Compound (3C) is (2S,3R,4R,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., empagliflozin.

[0419] [Chemical formula 36]

[0420]

[0421] Triethylsilane (TES) (44 μL, 0.276 mmol) was added dropwise to a dichloromethane (CH2Cl2) solution (1.5 mL) of compound (2C) (60 mg, 0.130 mmol) at -15°C, and then, boron trifluoride ether complex (BF3·Et2O) (39 mg, 0.276 mmol) was slowly added over 10 minutes, and stirred at -10°C for 1 hour. The progress of the reaction was monitored by TLC. The reaction mixture was diluted with ethyl acetate (10 mL), and a saturated aqueous solution of sodium bicarbonate (5 mL) was added to adjust the pH to 7-8, thereby quenching the reaction. The organic layer was separated, washed with water (5 mL), dried with sodium sulfate, and filtered. The organic layer was concentrated by vacuum suction at 40-50°C to obtain a crude residue. The crude residue was purified by column chromatography (methanol / chloroform = 1 / 9) to obtain 41 mg (yield: 73%) of Compound (3C) as a white solid.

[0422] The analysis results of the obtained compound (3C) are shown below.

[0423] 1 H NMR (500MHz, DMSO-d6, 25°C): δ7.85 (d, J=8.1Hz, 1H), 7.74 (d, J=7.5Hz, 1H), 7.41 (dd, J=7.5 , 2.1Hz, 1H), 7.35-7.24 (m, 3H), 7.16 (t, J=9.2Hz, 2H), 4.93 (d, J=5.2Hz, 2H), 4.80 (d, J=5. 7Hz, 1H), 4.44 (t, J=5.8Hz, 1H), 4.26 (q, J=15.6Hz, 2H), 4.02 (d, J=9.4Hz, 1H), 3.72 (tdd, J =11.7, 5.3, 1.7Hz, 1H), 3.46 (dt, J = 11.8, 5.9Hz, 1H), 3.31-3.22 (m, 2H), 3.21-3.12 (m, 2H).

[0424] 13C NMR (126MHz, DMSO-d6, 25℃): δ160.75, 158.81, 143.98, 139.79, 139.09, 136.96, 130.72, 130.69, 128.52, 128.46, 125.7 4, 125.62, 124.50, 124.00, 123.23, 122.41, 121.80, 114.89, 114.72, 81.40, 80.87, 78.53, 74.91, 70.52, 61.55, 29.69.

[0425] HRMS: [M+Na] + C 21 H 21 O5FNa calculated value: 427.0985, measured value: 427.0986.

[0426] <Production Example 3>

[0427] According to the following reaction formula, compound (5) is prepared from compound (4), and compound (1D') is prepared from compound (5). Compound (1D') is (2R,3R,4S,5R)-6-(4-chloro-3-(4-(((R)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-oxohexane-1,2,3,4,5-pentayl pentaacetate.

[0428] [Chemical formula 37]

[0429]

[0430] To a solution (3 mL) of compound (4) (250 mg, 0.615 mmol, 1.0 equiv) in dichloromethane (DCM) was added N,N-dimethylformamide (DMF) (exactly 2-3 drops, about 0.05 equiv), and then oxalyl chloride (COCl) 2 (156 mg, 1.231 mmol, 2.0 equiv) was added at 0°C. The reaction mixture was stirred at room temperature for 2 hours under an argon atmosphere. The progress of the reaction was monitored by TLC. The reaction mixture was evaporated and co-distilled with toluene (2.0 mL). Finally, the residue was dried by vacuum suction for 2 hours to obtain compound (5). The obtained compound (5) was used directly in the subsequent operation.

[0431] In an oven-dried Schlenk tube, 1,2-dibromoethane (0.050 mL, exactly 1-2 drops) was added to a mixture containing flaked magnesium (30 mg, 1.231 mmol, 2.0 equivalents) and tetrahydrofuran (THF) (3 mL, 10 volumes) under an argon atmosphere. Then, (R)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran (226 mg, 0.615 mmol, 1.0 equivalents) was added under an argon atmosphere. Then, the reaction mixture was refluxed at 75-80°C for 3 hours. After cooling to room temperature, the reaction mixture was transferred to another Schlenk tube using THF (1 mL×2). Thus, a Grignard reagent was prepared.

[0432] In another oven-dried Schlenk tube, a THF solution (2 mL×1) of compound (5) was added to a suspension of CuCN (55 mg, 0.615 mmol, 1.0 equiv.) and THF (1 mL) at -15°C. Then, the Grignard reagent prepared above was added dropwise to the reaction mixture at -15°C over 30 minutes, and stirred at -15°C for 1 hour. The reaction was monitored by TLC. The reaction was quenched with water (0.5 mL, 2 volumes). The reaction mixture was filtered through a celite pad, and the filter bed was washed with ethyl acetate (10 mL×2). The filtrate was dried over anhydrous sodium sulfate and filtered. The solvent was removed by vacuum suction to obtain a crude compound. The crude compound was purified by silica gel column chromatography (ethyl acetate / n-hexane=1 / 9 to 4 / 6) to obtain 234 mg (yield 72%) of compound (1D') as an off-white fluffy solid.

[0433] The analysis results of the obtained compound (1D') are shown below.

[0434] FTIR(NaCl): 2997, 1680, 1509, 1372, 1218, 1045cm -1 ;

[0435] 1H NMR (500MHz, CDCl3, 25°C): δ7.74 (d, J=2.1Hz, 1H), 7.72 (d, J=2.2Hz, 1H), 7.70 (d, J=2.2Hz, 1H), 7.12-7.0 8 (m, 1H), 6.82-6.77 (m, 1H), 6.00 (d, J=5.2Hz, 1H), 5.67 (dd, J=5.1, 4.3Hz, 1H), 5.45 (dd, J=7.0, 4.3Hz, 1 H), 5.13-5.06 (m, 1H), 4.95-4.82 (m, 1H), 4.30 (dd, J=12.5, 3.0Hz, 1H), 4.13-4.06 (m, 3H), 4.00-3.92 (m, 3H), 3.89 (dd, J=8.2, 4.5Hz, 1H), 2.23-2.11 (m, 2H), 2.10 (s, 3H), 2.05 (s, 3H), 2.04 (s, 6H), 1.93 (s, 3H).

[0436] 13 C NMR (126MHz, CDCl3, 25℃): δ192.45, 170.72, 169.88, 169.72, 169.52, 156.18, 140.33, 140.09, 133.63, 131.03, 131.00, 130.17, 130.07, 130.0 6, 127.57, 115.60, 115.59, 115.58, 77.39, 73.16, 72.44, 69.39, 68.74, 68.57, 67.24, 61.80, 38.36, 33.07, 20.81, 20.73, 20.58, 20.42, 20.36.

[0437] HRMS: [M+Na] + C 33 H 37 O 13 Calculated value of NaCl: 699.1815, measured value: 699.1823.

[0438] [Example 9]

[0439] Compound (2D) is prepared from compound (1D') according to the following reaction formula. Compound (2D) is (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol, an intermediate of empagliflozin.

[0440] [Chemical formula 38]

[0441]

[0442] At -15°C, a solution of compound (1D') (100 mg, 0.147 mmol) in tetrahydrofuran (THF) (1 mL) was added dropwise with a methanol (MeOH) solution (2 mL) of sulfuric acid (H2SO4) (63 μL, 1.181 mmol), stirred at -15°C for 2 hours, then slowly allowed to warm to room temperature, and stirred at room temperature for 12 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and aqueous sodium bicarbonate solution (10 mL) were added to the reaction mixture to quench the reaction. Next, the organic layer was separated, dried over sodium sulfate, and concentrated by vacuum suction to obtain a crude product in the form of a sticky off-white solid. The obtained crude product was purified by column chromatography (methanol / chloroform = 0.5 / 9.5) to obtain 47 mg (yield 66%) of compound (2D) in the form of an off-white amorphous solid.

[0443] The analysis results of the obtained compound (2D) are shown below.

[0444] 1 H NMR (500MHz, CDCl3, 25°C): δ7.34 (s, 1H), 7.24 (d, J=8.3Hz, 1H), 7.20 (d, J=8.2Hz, 1H), 7.03 (d , J=8.5Hz, 2H), 6.68(d, J=8.5Hz, 2H), 5.18(s, 1H), 5.07(s, 1H), 4.78(s, 1H), 4.22(s, 1H), 4. 03-3.88 (m, 3H), 3.84 (t, J=7.1Hz, 3H), 3.82-3.75 (m, 3H), 3.56 (t, J=9.0Hz, 1H), 3.49 (d, J=9 .5Hz, 1H), 3.36 (s, 1H), 3.17 (d, J=8.8Hz, 1H), 2.84 (s, 3H), 2.63 (bs, 2H), 2.15-1.99 (m, 2H).

[0445] [Example 10]

[0446] Compound (2D) can be produced from compound (1D') according to the following reaction formula.

[0447] [Chemical formula 39]

[0448]

[0449] At -15°C, a solution of compound (1D') (300 mg, 0.44 mmol, 1.0 equivalent) in tetrahydrofuran (THF) (1.5 mL) was added dropwise with a methanol (MeOH) solution (3 mL) of methanesulfonic acid (MSA) (195 μL, 2.20 mmol, 5.0 equivalent), and stirred at -15°C for 2 hours, then slowly allowed to warm to room temperature and stirred for 12 hours. TLC confirmed that the reaction was not completed (unconsumed compound (1D') remained), so additional MSA (78 μL, 0.88 mmol, 2.0 equivalent) was added to the reaction mixture, and stirring was further continued for 12 hours. The completion of the reaction was confirmed by TLC. Ethyl acetate (10 mL) and an aqueous sodium bicarbonate solution (10 mL) were added to the reaction mixture. Next, the organic layer was separated, dried over sodium sulfate, and concentrated by vacuum suction. The crude compound was purified by silica gel column chromatography (SiO2 230-400, eluted with 30% ethyl acetate in hexane) to obtain purified Compound (2D) (166 mg, yield: 78%) as a sticky solid.

[0450] The analysis results of the obtained compound (2D) are shown below.

[0451] 1 H NMR (500MHz, CDCl3): δ7.34 (s, 1H), 7.23-7.18 (m, 2H), 7.01 (d, J=8.0Hz, 2H), 6.66 (d, J=8.0Hz, 2H), 5.21 (s, 1H), 5.07 (s, 1H), 4.76 (s, 1H), 4.24 (s, 1H), 3.99-3.76 (m, 9H), 3.57-3.47 (m, 2H), 3.16 (d, J=8Hz, 1H), 2.83 (s, 3H), 2.08-2.05 (m, 2H).

[0452] [Example 11]

[0453] Compound (3D) is prepared from compound (2D) according to the following reaction formula. Compound (3D) is (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, i.e., empagliflozin.

[0454] [Chemical formula 40]

[0455]

[0456] Triethylsilane (TES) (51 μL, 0.318 mmol, 2 equiv) was added dropwise to a solution (1.5 mL) of compound (2D) (72 mg, 0.15 mmol, 1 equiv) in dichloromethane (CH2Cl2) at -15°C, and boron trifluoride etherate (BF3·Et2O) (67 mg, 0.318 mmol, 2 equiv) was slowly added over 10 minutes, and the mixture was stirred at -10°C for 1 hour. The progress of the reaction was monitored by TLC. After the reaction was completed, the reaction mixture was diluted with ethyl acetate (10 mL), and a saturated aqueous solution of sodium bicarbonate (5 mL) was added to adjust the pH to 7-8, thereby quenching the reaction. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The combined organic layers were concentrated by vacuum suction at 40-50°C to obtain a crude product in the form of a solid. The obtained crude product was crystallized using ethyl acetate (2 mL) and hexane (10 mL). The obtained crystals were filtered, washed with hexane, and dried to obtain the final product, Compound (3D) (59 mg, yield: 88%), as a white solid.

[0457] The analysis results of the obtained compound (3D) are shown below.

[0458] 1 H NMR (500MHz, CDCl3): δ7.24-7.10(m, 3H), 7.03-6.98(m, 2H), 6.69-6.64(m, 2H), 5.15-4.95(m, 2H), 4.70(s, 1H), 4.10-2.93(m, 15H), 2.04-2.01(m, 2H).

[0459] [Example 12]

[0460] Compound (3D) can be produced from compound (2D) according to the following reaction formula.

[0461] [Chemical formula 41]

[0462]

[0463] Triethylsilane (TES) (51 μL, 0.20 mmol, 2 equiv) was added dropwise to a solution (1.0 mL) of compound (2D) (48 mg, 0.10 mmol, 1 equiv) in anhydrous dichloromethane (CH2Cl2) at -15°C, and then boron trifluoride tetrahydrofuran complex (BF3·THF) (28.0 mg, 0.20 mmol, 2 equiv) was slowly added over 10 minutes, and the mixture was stirred at 0°C for 1 hour. The progress of the reaction was monitored by TLC. After the reaction was completed, the reaction mixture was diluted with ethyl acetate (10 mL), and a saturated aqueous solution of sodium bicarbonate (5 mL) was added to adjust the pH to 7-8, thereby quenching the reaction. The organic layer was separated, washed with water (5 mL), dried over sodium sulfate, and filtered. The combined organic layers were concentrated by vacuum suction at 40-50°C to obtain a crude product in the form of a solid. The obtained crude product was crystallized using ethyl acetate (2 mL) and hexane (10 mL). The obtained crystals were filtered, washed with hexane, and then dried to obtain the final product, Compound (3D) (33.8 mg, yield: 75%), as a white solid.

[0464] The analysis results of the obtained compound (3D) are shown below.

[0465] 1 H NMR (500MHz, DMSO-D6): δ7.35-7.25 (m, 2H), 7.20-7.16 (m, 1H), 7.09-7.06 (m, 2H), 6.80 (d, J=8.5Hz, 2H), 4.92-4.90 (m, 3H), 4.78 (d, J=5.0Hz, 1H), 4.40 (t, J=6.0Hz, 1H), 3.98-3.66 (m, 8H), 3.45-3.40 (m, 1H), 3.26-3.06 (m, 4H), 2.18-2.11 (m, 1H), 1.92-1.87 (m, 1H).

Claims

1. A method for producing a compound (III) represented by the following formula (III), the method comprising the following steps: Compound (III) is produced by contacting a compound (I) selected from a compound (Ia) represented by the following formula (Ia) and a compound (Ib) represented by the following formula (Ib) with an acid in a solvent containing an alcohol (II) represented by the following formula (II), [Chemical formula 1] In formula (III), Ar represents an alkyl group which may have a substituent, an alkenyl group which may have a substituent, a cycloalkyl group which may have a substituent, a heterocycloalkyl group which may have a substituent, an aryl group which may have a substituent, a heteroaryl group which may have a substituent, an arylalkyl group which may have a substituent, or an arylalkenyl group which may have a substituent, R 100 represents an alkyl group which may have a substituent, [Chemical formula 2] In formula (Ia), R each independently represents an alkyl group which may have a substituent or an aryl group which may have a substituent, Ar has the same meaning as above, [Chemical formula 3] In formula (Ib), R and Ar have the same meanings as above, [Chemical formula 4] R 100 -OH(II) In formula (II), R 100 has the same meaning as above.

2. The method of claim 1, wherein: The compound (I) is contacted with the acid in the solvent at a temperature of -80°C to 40°C.

3. The method according to claim 1 or 2, wherein: The alcohol (II) is an alcohol having 1 to 5 carbon atoms.

4. The method of claim 3, wherein: The alcohol (II) is methanol.

5. The method according to claim 1 or 2, wherein: The acid is a compound (IV) represented by the following formula (IV), [Chemical formula 5] In formula (IV), R 200 It represents an alkyl group which may have a substituent or an aryl group which may have a substituent.

6. The method according to claim 1 or 2, wherein: The acid is sulfuric acid.

7. A method for producing a compound (V) represented by the following formula (V), the method comprising the following steps: After producing compound (III) by the method according to claim 1 or 2, the produced compound (III) is brought into contact with a silane compound in the presence of a Lewis acid to produce the compound (V), [Chemical formula 6] In formula (V), Ar has the same meaning as above.